Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Detailed Quote:KCG
KNIGHT CAPITAL GROUP INC
12.1800-0.2600 (-2.09%)AS OF 10:53:39AM ET 08/31/2010
Last Trade 12.1800
Trade Time 10:53:39AM ET
Last Trade Exchange NYSE
Today's Change -0.2600
Today's % Change -2.09%
Open 12.40
Day High 12.4100
Day Low 12.12
Previous Close Price
08/30/2010 12.4400
52-Week High
10/14/2009 23.1100
52-Week Low
08/27/2010 12.3200
Volume 509,930
Average Volume (10-Day) 1,449,796
Average Volume (90-Day) 1,560,138
--
4kids
all jmo
Knight Capital Group Inc sets a new 52-week low
BY Wall Street on Demand
— 9:46 AM ET 08/31/2010
Knight Capital Group Inc (KCG) crossed below its 52-week low of $12.32 on 9:45 AM ET on August 31, 2010.
--
4kids
all jmo
Channel Trend Inc. downgrades KNIGHT CAP GROUP INC from NEUTRAL to UNFAVORABLE.
INVESTARS ANALYST ACTIONS - PRIVATE – 08/29/2010
Ford Equity Research downgrades KNIGHT CAP GROUP INC from MOST FAVORABLE to FAVORABLE.
INVESTARS ANALYST ACTIONS - PRIVATE – 08/29/2010
Market Edge downgrades KNIGHT CAP GROUP INC from BUY to HOLD.
INVESTARS ANALYST ACTIONS - PRIVATE – 08/29/2010
3 downgrades in one day .. hmmm .. how very telling
--
4kids
all jmo
Knight Capital Group Inc sets a new 52-week low
BY Wall Street on Demand
— 10:02 AM ET 08/26/2010
Knight Capital Group Inc (KCG) crossed below its 52-week low of $12.51 on 10:01 AM ET on August 26, 2010.
--
4kids
all jmo
Detailed Quote:KCG
KNIGHT CAPITAL GROUP INC
12.3900-0.1900 (-1.51%)AS OF 4:01:08PM ET 08/26/2010
Last Trade 12.3900
Trade Time 4:01:08PM ET
Last Trade Exchange NYSE
Today's Change -0.1900
Today's % Change -1.51%
Open 12.6300
Day High 12.640000
Day Low 12.3200
Previous Close Price
08/25/2010 12.5800
52-Week High
10/14/2009 23.1100
52-Week Low
08/25/2010 12.5100
Volume 1,424,624
Average Volume (10-Day) 1,320,693
Average Volume (90-Day) 1,695,382
---
4kids
all jmo
Knight Capital Group Inc sets a new 52-week low
BY Wall Street on Demand
— 9:58 AM ET 08/25/2010
Knight Capital Group Inc (KCG) crossed below its 52-week low of $12.54 on 9:57 AM ET on August 25, 2010.
Detailed Quote:KCG
KNIGHT CAPITAL GROUP INC
12.66180.0718 (0.57%)AS OF 10:52:43AM ET 08/25/2010
Open 12.56
Day High 12.6800
Day Low 12.5100
Previous Close Price
08/24/2010 12.5900
52-Week High
10/14/2009 23.1100
52-Week Low
08/24/2010 12.5400
Volume 289,475
Average Volume (10-Day) 1,298,845
Average Volume (90-Day) 1,711,286
---
4kids
all jmo
Detailed Quote:KCG
KNIGHT CAPITAL GROUP INC
12.5900-0.0800 (-0.63%)AS OF 4:02:44PM ET 08/24/2010
Last Trade 12.5900
Trade Time 4:02:44PM ET
Last Trade Exchange NYSE
Today's Change -0.0800
Today's % Change -0.63%
Open 12.56
Day High 12.7300
Day Low 12.5400
Previous Close Price
08/23/2010 12.6700
52-Week High
10/14/2009 23.1100
52-Week Low
08/23/2010 12.6400
Volume 1,384,373
Average Volume (10-Day) 1,282,366
Average Volume (90-Day) 1,719,789
--
4kids
all jmo
Ativo Research downgrades KNIGHT CAP GROUP INC
from UNFAVORABLE to MOST UNFAVORABLE.
Investars Analyst Actions - private - 7:21 PM ET 08/21/2010
---
interesting to note that kcg's new 52 week low was *again*
reset yesterday ~ and once again this am ~ let's see what
else today has to bring re: pps
---
Open 12.56
Day High 12.6600
Day Low 12.5400
Previous Close Price
08/23/2010 12.6700
52-Week High
10/14/2009 23.1100
52-Week Low
08/23/2010 12.6400
---
4kids
all jmo
let's put it this way
won't bother me one iota if knight is crushed
into oblivion and puts a few *employees* out of work
i see zero reason for MM's to exist period
but when one MM like knight *controls* a
monopoly .. imo the sec should be all over that
i find it telling that because the monopoly
*controlled* is on the OTC (with few sets of eyes
to *record* aspects) that this bs has gone on for well
over 3 years ..
--
very curious to see what nite's pps is come 10/21
and more importantly what is *asked* at their CC
--
4kids
all jmo
By then it might be Good Night
to the STAINED KNIGHT!
BMFL
next week(s) is here
it certainly has been a *DUD* of a stock
to hold for the past year ~ very curious
what is *announced* by mgmt when their next
CC is held on or around 10/21/2010
at that point in time it will have been a year
of said downward spiral on the KCG/NITE's PPS
and imo if kcg breaks 10.00 bucks LT SOR should be
very nervous as to who else might pile on re: a new short
notice dates of 52 week high and 52 week low
and volume ~
52-Week High
10/14/2009 23.11
52-Week Low
08/20/2010 12.71
KCG Volume 602,241
Average Volume (10-Day) 1,164,752
Average Volume (90-Day) 1,719,852
--
4kids
all jmo
Slow, Steady, Downward Spiral for the STAINED KNIGHT!
BMFL
next week(s) is here
time will tell :)
true what goes around comes around
which is why i'd be concerned if i
were a long holding kcg ~ today's
new 52 week low may be a trend in
the making .. interesting to see
their daily/10 day and 90 day avgs
are all *closely* aligned as well
--
Detailed Quote:KCG
KNIGHT CAPITAL GROUP INC
12.7400-0.2100 (-1.62%)AS OF 4:01:41PM ET 08/20/2010
Last Trade 12.7400
Trade Time 4:01:41PM ET
Last Trade Exchange NYSE
Today's Change -0.2100
Today's % Change -1.62%
Bid 12.6700
Bid Size 2
Bid Exchange Pacific
Ask 12.8200
Ask Size 1
Ask Exchange Pacific
Primary Exchange NYSE
Currency USD
Open 12.91
Day High 12.95
Day Low 12.7100
Previous Close Price
08/19/2010 12.9500
52-Week High
10/14/2009 23.1100
52-Week Low
08/19/2010 12.9400
Volume 1,828,148
Average Volume (10-Day) 1,034,144
Average Volume (90-Day) 1,723,464
Market Capitalization $1.22B
Shares Outstanding 94,593,000
Shares Short* 8,202,261
---
imo the folks who will take a short if kcg breaks 10.00 bucks
will be rather large *all things considered* ~ anyhow we'll
see what comes to pass over the coming weeks
--
4kids
all jmo
You know it looks to me like this puppy is being painted red. If I did not know better I would think that poor Knight was being taken advantage of. You folks have got to stop selling. Everytime I buy mine he takes it down. De ja vous all over again. What goes around comes around.
i stand corrected Open 12.91
the new 52 week low on kcg
was indeed hit yesterday
but *then* it was 12.94
not 12.95 as i posted :0
today .. a new 52 week low
has been hit and it's only
10:08 in the morning :)
---
Day High 12.95
Day Low 12.8200
Previous Close Price
08/19/2010 12.9500
52-Week High
10/14/2009 23.1100
52-Week Low
08/19/2010 12.9400
---
imo if this breaks 12.00 imo it will break 10.00
and if it breaks 10.00 .. the *shorts* will
pile on and then it will be very interesting
to see what is revealed by knight's mgmt
re: all sorts of subjects
--
4kids
all jmo
Detailed Quote:KCG
KNIGHT CAPITAL GROUP INC
13.13-0.3400 (-2.52%)AS OF 11:37:22AM ET 08/19/2010
Last Trade 13.13
Trade Time 11:37:22AM ET
Last Trade Exchange BATS
Today's Change -0.3400
Today's % Change -2.52%
Open 13.41
Day High 13.4700
Day Low 13.0800
Previous Close Price
08/18/2010 13.4700
52-Week High
10/14/2009 23.11
52-Week Low
07/06/2010 13.25
Volume 475,554
Average Volume (10-Day) 912,643
Average Volume (90-Day) 1,717,087
--
4kids
all jmo
Knight Capital Group Inc sets a new 52-week low
BY Wall Street on Demand
— 10:01 AM ET 08/19/2010
Knight Capital Group Inc (KCG) crossed below its 52-week low of $13.25 on 10:00 AM ET on August 19, 2010.
karma is one interesting *master*
--
4kids
all jmo
That's not really a big enough dip for me. Let's see what I can do. Knights stock should be lower. That way I could say that Knight was the lowest.
Knight Capital's Trading Volume Declines In July
BY Dow Jones & Company, Inc.
— 7:45 AM ET 08/13/2010
DOW JONES NEWSWIRES
Knight Capital Group Inc.'s (KCG)
U.S. equity trading volume fell in July, as traders continued to operate at diminished-activity levels after last year's turmoil.
Average daily U.S. stock trades at Knight during July were 3.7 million, down 5.7% from June and 2.3% from a year earlier. On a dollar basis, trading decreased 7.1% sequentially and but rose 13% on the year to $25.42 billion. Daily average volume by number of shares was 7.38 billion, down 15% and 27%, respectively.
Save for a short period earlier this year in which stock-market volatility was significantly boosted as markets were shocked by the "flash crash" in May, trading has generally declined as stocks slumped to a bottom in March 2009 before rebounding sharply.
Knight last month said its second-quarter earnings jumped 53% as the company benefited from that brief boost in trading because of stock-market volatility.
Shares of Knight closed at $14.03 on Thursday and were inactive premarket. The stock has fallen 24% in the past year.
-By Nathan Becker, Dow Jones Newswires; 212-416-2855; nathan.becker@ dowjones.com
----
Detailed Quote:KCG
KNIGHT CAPITAL GROUP INC
13.4700-0.0700 (-0.52%)AS OF 4:01:35PM ET 08/18/2010
Last Trade 13.4700
Trade Time 4:01:35PM ET
Last Trade Exchange NYSE
Today's Change -0.0700
Today's % Change -0.52%
Open 13.5200
Day High 13.6500
Day Low 13.4200
Previous Close Price
08/17/2010 13.5400
52-Week High
10/14/2009 23.11
52-Week Low
07/06/2010 13.25
Volume 890,642
Average Volume (10-Day) 910,956
Average Volume (90-Day) 1,730,892
---
4kids
all jmo
Anyone who says they hate NITE can come over to TEVE and join the squeeze.
Too late for Knight!
next week(s) is here
nite needs to pull that file lol double check
Is NITES insurance up to date?
next week(s) is here
credit extension time lol
Fly on the Wall
I would like to be a Fly on the Wall at NITE right now, with the Dividend Announcement COMING 8/02/10 8:00 am.
next week(s) is here
Maybe we should start shorting this POS and paint them red each night as they do with real company's.
Hello Nite! Just checking in.See times are getting hard for you also.No more $15-$16 shares days.Lets hope you see $11 sooner then you think....(HESG)
That was excellent, Texan77, and fwiw, there is much much more here:
http://www.counterfeitingstock.com/CS2.0/CounterfeitingStock20Full.pdf
Original source:
Citizens for Securities Reform
http://www.counterfeitingstock.com/
I see 'they' have deleted your post at "The Authoritative NSS Page (NAKED)" board.
Counterfeiting Stock
Illegal naked shorting and stock manipulation are two of Wall Street's deep, dark secrets. These practices have been around for decades and have resulted in trillions of dollars being fleeced from the American public by Wall Street. In the process, many emerging companies have been put out of business. This report will explain the magnitude of this problem, how it happens, why it has been covered up and how short sellers attack a company. It will also show how all of the participants; the short hedge funds, the prime brokers and the Depository Trust Clearing Corp. (DTCC) — make unconscionable profits while the fleecing of the small American investor continues unabated.
Why is This Important? This problem affects the investing public. Whether invested directly in the stock market or in mutual funds, IRAs, retirement or pension plans that hold stock — it touches the majority of Americans.
The participants in this fraud, which, when fully exposed, will make Enron look like child's play, have been very successful in maintaining a veil of secrecy and impenetrability. Congress and the SEC have unknowingly (?) helped keep the closet door closed. The public rarely knows when its pocket is being picked as unexplained drops in stock price get chalked up to “market forces” when they are often market manipulations.
The stocks most frequently targeted are those of emerging companies who went to the stock market to raise start–up capital. Small business brings the vast majority of innovative new ideas and products to market and creates the majority of new jobs in the United States. Over 1000 of these emerging companies have been put into bankruptcy or had their stock driven to pennies by predatory short sellers.
It is important to understand that selling a stock short is not an investment in American enterprise. A short seller makes money when the stock price goes down and that money comes solely from investors who have purchased the company's stock. A successful short manipulation takes money from investment in American enterprise and diverts it to feed Wall Street's insatiable greed — the company that was attacked is worse off and the investing public has lost money. Frequently this profit is diverted to off–shore tax havens and no taxes are paid. This national disgrace is a parasite on the greatest capital market in the world.
A Glossary of Illogical Terms — The securities industry has its own jargon, laws and practices that may require explaining. Most of these concepts are the creation of the industry, and, while they are promoted as practices that ensure an orderly market, they are also exploited as manipulative tools. This glossary is limited to naked short abuse, or counterfeiting stock as it is more correctly referred to.
1. Broker Dealer or Prime Broker — The big stockbrokers who clear their own transactions, which is to say they move transacted shares between their customers directly, or with the DTC. Small brokers will clear through a clearing house — also known as a broker's broker.
2. Hedge Funds — Hedge funds are really unregulated investment pools for rich investors. They have grown exponentially in the past decade and now number over 10,000 and manage over one trillion dollars. They don't register with the SEC, are virtually unregulated and frequently foreign domiciled, yet they are allowed to be market makers with access to all of the naked shorting loopholes. Frequently they operate secretively and collusively. The prime brokers cater to the hedge funds and allegedly receive eight to ten billion dollars annually in fees and charges relating to stock lend to the short hedge funds.
3. Market Maker — A broker, broker dealer or hedge fund who makes a market in a stock. In order to be a market maker, they must always have shares available to buy and sell. Market makers get certain sweeping exemptions from SEC rules involving naked shorting.
4. Short Seller — An individual, hedge fund, broker or institution who sells stock short. The group of short sellers is referred to as “the shorts.”
5. The Securities and Exchange Commission — The SEC is the federal enforcement agency that oversees the securities markets. The top–level management is a five–person Board of Governors who are Presidential appointees. Three of the governors are usually from the securities industry, including the chairman. The SEC adopted Regulation SHO in January 2005 in an attempt to curb naked short abuse.
6. Depository Trust Clearing Corp — Usually known as the DTCC, this privately held company is owned by the prime brokers and it clears, transacts and holds most stock in this country. It has four subsidiaries, which include the DTC and the NCSS. The operation of this company is described in detail later.
7. Short Sale — Selling a stock short is a way to make a profit while the stock price declines. For example: If investor S wishes to sell short, he borrows a share from the account of investor L. Investor S immediately sells that share on the open market, so investor S now has the cash from the sale in his account, and investor L has an IOU for the share from investor S. When the stock price drops, investor S takes some of the money from his account and buys a share, called “covering”, which he returns to investor L's account. Investor S books a profit and investor L has his share back.
This relatively simple process is perfectly legal – so far. The investor lending the share most likely doesn't even know the share left his account, since it is all electronic and occurs at the prime broker or DTC level. If shares are in a margin account, they may be loaned to a short without the consent or knowledge of the account owner. If the shares are in a cash account, IRA account or are restricted shares they are not supposed to be borrowed unless there is express consent by the account owner.
8. Disclosed Short — When the share has been borrowed or a suitable share has been located that can be borrowed, it is a disclosed short. Shorts are either naked or disclosed, but, in reality, some disclosed shorts are really naked shorts as a result of fraudulent stock borrowing.
9. Naked Short — This is an invention of the securities industry that is a license to create counterfeit shares. In the context of this document, a share created that has the effect of increasing the number of shares that are in the market place beyond the number issued by the company, is considered counterfeit. This is not a legal conclusion, since some shares we consider counterfeit are legal based upon today's rules. The alleged justification for naked shorting is to insure an orderly and smooth market, but all too often it is used to create a virtually unlimited supply of counterfeit shares, which leads to widespread stock manipulation – the lynchpin of this massive fraud.
Returning to our example, everything is the same except the part about borrowing the share from someone else's account: There is no borrowed share — instead a new one is created by either the broker dealer or the DTC. Without a borrowed share behind the short sale, a naked short is really a counterfeit share.
10. Fails–to–Deliver — The process of creating shares via naked shorting creates an obvious imbalance in the market as the sell side is artificially increased with naked short shares or more accurately, counterfeit shares. Time limits are imposed that dictate how long the sold share can be naked. For a stock market investor or trader, that time limit is three days. According to SEC rules, if the broker dealer has not located a share to borrow, they are supposed to take cash in the short account and purchase a share in the open market. This is called a “buy–in,” and it is supposed to maintain the total number of shares in the market place equal to the number of shares the company has issued.
Market makers have special exemptions from the rules: they are allowed to carry a naked short for up to twenty–one trading days before they have to borrow a share. When the share is not borrowed in the allotted time and a buy–in does not occur, and they rarely do, the naked short becomes a fail–to–deliver (of the borrowed share).
11. Options — The stock market also has separate, but related markets that sell options to purchase shares (a “call”) and options to sell shares (a “put”). This report is only going to deal with calls; they are an integral part of short manipulations. A call works as follows: Assume investor L has a share in his account that is worth $25. He may sell an option to purchase that share to a third party. That option will be at a specific price, say $30, and expires at a specific future date. Investor L will get some cash from selling this option. If at the expiration date, the market value of the stock is below $30 (the “strike price”), the option expires as worthless and investor L keeps the option payment. This is called “out of the money.” If the market value of the stock is above the strike price, then the buyer of the option “calls” the stock. Assume the stock has risen to $40. The option buyer tenders $30 to investor L and demands delivery of the share, which he may keep or immediately sell for a $10 profit.
12. Naked call — The same as above except that investor L, who sells the call, has no shares in his account. In other words, he is selling an option on something he does not own. The SEC allows this. SEC rules also allow the seller of a naked short to treat the purchase of a naked call as a borrowed share, thereby keeping their naked short off the SEC's fails–to–deliver list.
How The System Transacts Stocks — This explanation has been greatly simplified in the interest of brevity.
1. Customers — These can be individuals, institutions, hedge funds and prime broker's house accounts.
2. Prime Brokers — They both transact and clear stocks for their customers. Examples of prime brokers include Goldman Sachs; Merrill Lynch; Citigroup; Morgan Stanley; Bear Stearns, etc.
3. The DTCC — This is the holding company that owns four companies that clear and keep track of all stock transactions. This is where brokerage accounts are actually lodged. The DTC division clears over a billion shares daily. The DTCC is owned by the prime brokers, and, as a closely held private enterprise, it is impenetrable. It actively and aggressively fights all efforts to obtain information regarding naked shorting, with or without a subpoena.
Stocks clear as follows:
If customer A–1 purchases ten shares of XYZ Corp and Customer A–2 sells ten shares, then the shares are transferred electronically, all within prime broker A. Record of the transaction is sent to the DTC. Likewise, if Investor A–1 shorts ten shares of XYZ Corp and Investor A–2 has ten shares in a margin account, prime broker A borrows the shares from account A–2 and for a fee lends them to A–1.
If Customer A–1 sells shares to Customer B–2, in order to get the shares to B–2 and the money to A–1, the transaction gets completed in the DTC. The same occurs for shares that are borrowed on a short sale between prime brokers.
As a practical matter, what happens is prime broker A, at the end of the day, totals all of his shares of XYZ owned and all of the XYZ shares bought and sold, and clears the difference through the DTC. In theory, at the end of each day when all of the prime brokers have put their net positions in XYZ stock through the system, they should all cancel out and the number of shares in the DTC should equal the number of shares that XYZ has sold into the market. This almost never happens, because of the DTC stock borrow program which is discussed later.
Who are the Participants in the Fraud? The participants subscribe to the theory that it is much easier to make money tearing companies down than making money building them up, and they fall into two general categories: 1) They participate in the process of producing the counterfeit shares that are the currency of the fraud and/or 2) they actively short and tear companies down.
The counterfeiting of shares is done by participating prime brokers or the DTC, which is owned by the prime brokers. A number of lawsuits that involve naked shorting have named about ten of the prime brokers as defendants, including Goldman Sachs, Bear Stearns, Citigroup, Merrill Lynch; UBS; Morgan Stanley and others. The DTCC has also been named in a number of lawsuits that allege stock counterfeiting.
The identity of the shorts is somewhat elusive as the shorts obscure their true identity by hiding behind the prime brokers and/or hiding behind layers of offshore domiciled shell corporations. Frequently the money is laundered through banks in a number of tax haven countries before it finally reaches its ultimate beneficiary in New York, New Jersey, San Francisco, etc. Some of the hedge fund managers who are notorious shorters, such as David Rocker and Marc Cohodes, are very public about their shorting, although they frequently utilize offshore holding companies to avoid taxes and scrutiny.
Most of the prime brokers have multiple offshore subsidiaries or captive companies that actively participate in shorting. The prime brokers also front the shorting of some pretty notorious investors. According to court documents or sworn testimony, if one follows one of the short money trails at Solomon, Smith Barney, it leads to an account owned by the Gambino crime family in New York. A similar exercise with other prime brokers, who cannot be named at this time, leads to the Russian mafia, the Cali drug cartel, other New York crime families and the Hell's Angels.
One short hedge fund that was particularly destructive was a shell company domiciled in Bermuda. Subpoenas revealed the Bermuda company was wholly owned by another shell company that was domiciled in another tax haven country. This process was five layers deep, and at the end of the subterfuge was a very well known American insurance company that cannot be disclosed because of court–ordered sealing of testimony.
Most of the large securities firms, insurance companies and multi–national companies have layers of offshore captives that avoid taxes, engage in activities that the company would not want to be publicly associated with, like stock manipulation; avoid U.S. regulatory and legal scrutiny; and become the closet for deals gone sour, like Enron.
The Creation of Counterfeit Shares — There are a variety of names that the securities industry has dreamed up that are euphemisms for counterfeit shares. Don't be fooled : Unless the short seller has actually borrowed a real share from the account of a long investor, the short sale is counterfeit. It doesn't matter what you call it and it may become non–counterfeit if a share is later borrowed, but until then, there are more shares in the system than the company has sold.
The magnitude of the counterfeiting is hundreds of millions of shares every day, and it may be in the billions. The real answer is locked within the prime brokers and the DTC. Incidentally, counterfeiting of securities is as illegal as counterfeiting currency, but because it is all done electronically, has other identifiers and industry rules and practices, i.e. naked shorts, fails–to–deliver, SHO exempt, etc. the industry and the regulators pretend it isn't counterfeiting. Also, because of the regulations that govern the securities, certain counterfeiting falls within the letter of the rules. The rules, by design, are fraught with loopholes and decidedly short on allowing companies and investors access to information about manipulations of their stock.
The creation of counterfeit shares falls into three general categories. Each category has a plethora of devices that are used to create counterfeit shares.
1. Fails–to–Deliver — If a short seller cannot borrow a share and deliver that share to the person who purchased the (short) share within the three days allowed for settlement of the trade, it becomes a fail–to–deliver and hence a counterfeit share; however the share is transacted by the exchanges and the DTC as if it were real. Regulation SHO, implemented in January 2005 by the SEC, was supposed to end wholesale fails–to–deliver, but all it really did was cause the industry to exploit other loopholes, of which there are plenty (see 2 and 3 below).
Since forced buy–ins rarely occur, the other consequences of having a fail–to–deliver are inconsequential, so it is frequently ignored. Enough fails–to–deliver in a given stock will get that stock on the SHO list, (the SEC's list of stocks that have excessive fails–to–deliver) – which should (but rarely does) see increased enforcement. Penalties amount to a slap on the wrist, so large fails–to–deliver positions for victim companies have remained for months and years.
A major loophole that was intentionally left in Reg SHO was the grandfathering in of all pre–SHO naked shorting. This rule is akin to telling bank robbers, “If you make it to the front door of the bank before the cops arrive, the theft is okay.”
Only the DTC knows for certain how many short shares are perpetual fails–to–deliver, but it is most likely in the billions. In 1998, REFCO, a large short hedge fund, filed bankruptcy and was unable to meet margin calls on their naked short shares. Under this scenario, the broker dealers are the next line of financial responsibility. The number of shares that allegedly should have been bought in was 400,000,000, but that probably never happened. The DTC — owned by the broker dealers — just buried 400,000,000 counterfeit shares in their system, where they allegedly remain — grandfathered into “legitimacy” by the SEC. Because they are grandfathered into “legitimacy”, the SEC, DTC and prime brokers pretend they are no longer fails–to–deliver, even though the victim companies have permanently suffered a 400 million share dilution in their stock.
Three months prior to SHO, the aggregate fails–to–deliver on the NASDAQ and the NYSE averaged about 150 million shares a day. Three months after SHO it dropped by about 20 million, as counterfeit shares found new hiding places (see 2 and 3 below). It is noteworthy that aggregate fails–to–deliver are the only indices of counterfeit shares that the DTC and the prime brokers report to the SEC. The bulk of the counterfeiting remains undisclosed, so don't be deceived when the SEC and the industry minimize the fails–to–deliver information. It is akin to the lookout on the Titanic reporting an ice cube ahead.
2. Ex–clearing counterfeiting — The second tier of counterfeiting occurs at the broker dealer level. This is called ex–clearing. Multiple tricks are utilized for the purpose of disguising naked shorts that are fails–to–deliver as disclosed shorts, which means that a share has been borrowed. They also make naked shorts “invisible” to the system so they don't become fails–to–deliver, which is the only thing the SEC tracks.
Some of the tricks are as follows:
* Stock sales are either a long sale or a short sale. When a stock is transacted the broker checks the appropriate box. By mismarking the trading ticket –checking the long box when it is actually a short sale the short never shows up, unless they get caught, which doesn't happen often. The position usually gets reconciled when the short covers.
* Settlement of stock transactions is supposed to occur within three days, at which time a naked short should become a fail–to–deliver, however the SEC routinely and automatically grants a number of extensions before the naked short gets reported as a fail–to–deliver. Most of the short hedge funds and broker dealers have multiple entities, many offshore, so they sell large naked short positions from entity to entity. Position rolls, as they are called, are frequently done broker to broker, or hedge fund to hedge fund, in block trades that never appear on an exchange. Each movement resets the time clock for the naked position becoming a fail–to–deliver and is a means of quickly getting a company off of the SHO threshold list.
* The prime brokers may do a buy–in of a naked short position. If they tell the short hedge fund that we are going to buy–in at 3:59 EST on Friday, the hedge fund naked shorts into their own buy–in (or has a co–conspirator do it) and rolls their position, hence circumventing Reg SHO.
* Most of the large broker dealers operate internationally, so when regulators come in (they almost always “call ahead”) or compliance people come in (ditto), large naked positions are moved out of the country and returned at a later date.
* The stock lend is enormously profitable for the broker dealers who charge the short sellers large fees for the “borrowed” shares, whether they are real or counterfeit. When shares are loaned to a short, they are supposed to remain with the short until he covers his position by purchasing real shares. The broker dealers do one–day lends, which enables the short to identify to the SEC the account that shares were borrowed from. As soon as the report is sent in, the shares are returned to the broker dealer to be loaned to the next short. This allows eight to ten shorts to borrow the same shares, resetting the SHO–fail–to–deliver clock each time, which makes all of the counterfeit shares look like legitimate shares. The broker dealers charge each short for the stock lend.
* Margin account buyers, because of loopholes in the rules, inadvertently aid the shorts. If short A sells a naked short he has three days to deliver a borrowed share. If the counterfeit share is purchased in a margin account, it is immediately put into the stock lend and, for a fee, is available as a borrowed share to the short who counterfeited it in the first place. This process is perpetually fluid with multiple parties, but it serves to create more counterfeit shares and is an example of how a counterfeit share gets “laundered” into a legitimate borrowed share.
* Margin account agreements give the broker dealers the right to lend those shares without notifying the account owner. Shares held in cash accounts, IRA accounts and any restricted shares are not supposed to be loaned without express consent from the account owner. Broker dealers have been known to change cash accounts to margin accounts without telling the owner, take shares from IRA accounts, take shares from cash accounts and lend restricted shares. One of the prime brokers recently took a million shares from cash accounts of the company's founding investors without telling the owners or the stockbroker who represented ownership. The shares were put into the stock lend, which got the company off the SHO threshold list, and opened the door for more manipulative shorting.
This is a sample of tactics used. For a company that is under attack, the counterfeit shares that exist at this ex–clearing tier can be ten or twenty times the number of fails–to–deliver, which is the only category tracked and policed by the SEC.
3. Continuous Net Settlement — The third tier of counterfeiting occurs at the DTC level. The Depository Trust and Clearing Corporation (DTCC) is a holding company owned by the major broker dealers, and has four subsidiaries. The subsidiaries that are of interest are the Depository Trust Company (DTC) and the National Securities Clearing Corporation (NSCC). The DTC has an account for each broker dealer, which is further broken down to each customer of that broker dealer. These accounts are electronic entries. Ninety seven percent of the actual stock certificates are in the vault at the DTC with the DTC nominee's name on them. The NSCC processes transactions, provides the broker dealers with a central clearing source, and operates the stock borrow program.
When a broker dealer processes the sale of a short share, the broker dealer has three days to deliver a borrowed share to the purchaser and the purchaser has three days to deliver the money. In the old days, if the buyer did not receive his shares by settlement day, three days after the trade, he took his money back and undid the transaction. When the stock borrow program and electronic transfers were put in place in 1981, this all changed. At that point the NSCC guaranteed the performance of the buyers and sellers and would settle the transaction even though the seller was now a fail–to–deliver on the shares he sold. The buyer has a counterfeit share in his account, but the NSCC transacts it as if it were real.
At the end of each day, if a broker dealer has sold more shares of a given stock than he has in his account with the DTC, he borrows shares from the NSCC, who borrows them from the broker dealers who have a surplus of shares. So far it sounds like the whole system is in balance, and for any given stock the net number of shares in the DTC is equal to the number of shares issued by the company.
The short seller who has sold naked – he had no borrowed shares – can cure his fail–to–deliver position and avoid the required forced buy–in by borrowing the share through the NSCC stock borrow program.
Here is the hocus pocus that creates millions of counterfeit shares.
When a broker dealer has a net surplus of shares of any given company in his account with the DTC, only the net amount is deducted from his surplus position and put in the stock borrow program. However the broker dealer does not take a like number of shares from his customer's individual accounts. The net surplus position is loaned to a second broker dealer to cover his net deficit position.
Let's say a customer at the second broker dealer purchased shares from a naked short seller — counterfeit shares. His broker dealer “delivers” those shares to his account from the shares borrowed from the DTC. The lending broker dealer did not take the shares from any specific customers' account, but the borrowing broker dealer put the borrowed shares in specific customer's accounts. Now the customer at the second prime broker has “real” shares in his account. The problem is it's the same “real” shares that are in the customer's account at the first prime broker.
The customer account at the second prime broker now has a “real” share, which the prime broker can lend to a short who makes a short sale and delivers that share to a third party. Now there are three investors with the same counterfeit shares in their accounts.
Because the DTC stock borrow program, and the debits and credits that go back and forth between the broker dealers, only deals with the net difference, it never gets reconciled to the actual number of shares issued by the company. As long as the broker dealers don't repay the total stock borrowed and only settle their net differences, they can “grow” a company's issued stock.
This process is called Continuous Net Settlement (CNS) and it hides billions of counterfeit shares that never make it to the Reg. SHO radar screen, as the shares “borrowed” from the DTC are treated as a legitimate borrowed shares.
For companies that are under attack, the counterfeit shares that are created by the CNS program are thought to be ten or twenty times the disclosed fails–to–deliver, and the true CNS totals are only obtained by successfully serving the DTC with a subpoena. The SEC doesn't even get this information. The actual process is more complex and arcane than this, but the end result is accurately depicted.
Ex–clearing and CNS counterfeiting are used to create an enormous reserve of counterfeit shares. The industry refers to these as “strategic fails–to–deliver.” Most people would refer to these as a stockpile of counterfeit shares that can be used for market manipulation. One emerging company for which we have been able to get or make reasonable estimates of the total short interest, the disclosed short interest, the available stock lend and the fails–to–deliver, has fifty “buried” counterfeit shares for every fail–to–deliver share, which is the only thing that the SEC tracks, consequently the SEC has not acted on shareholder complaints that the stock is being manipulated.
The Anatomy of a Short Attack — Abusive shorting are not random acts of a renegade hedge funds, but rather a coordinated business plan that is carried out by a collusive consortium of hedge funds and prime brokers, with help from their friends at the DTC and major clearinghouses. Potential target companies are identified, analyzed and prioritized. The attack is planned to its most minute detail.
The plan consists of taking a large short position, then crushing the stock price, and, if possible, putting the company into bankruptcy. Bankrupting the company is a short homerun because they never have to buy real shares to cover and they don't pay taxes on the ill-gotten gain.
When it is time to drive the stock price down, a blitzkrieg is unleashed against the company by a cabal of short hedge funds and prime brokers. The playbook is very similar from attack to attack, and the participating prime brokers and lead shorts are fairly consistent as well.
Typical tactics include the following:
1. Flooding the offer side of the board — Ultimately the price of a stock is found at the balance point where supply (offer) and demand (bid) for the shares find equilibrium. This equation happens every day for every stock traded. On days when more people want to buy than want to sell, the price goes up, and, conversely, when shares offered for sale exceed the demand, the price goes down.
The shorts manipulate the laws of supply and demand by flooding the offer side with counterfeit shares. They will do what has been called a short down ladder. It works as follows: Short A will sell a counterfeit share at $10. Short B will purchase that counterfeit share covering a previously open position. Short B will then offer a short (counterfeit) share at $9. Short A will hit that offer, or short B will come down and hit Short A's $9 bid. Short A buys the share for $9, covering his open $10 short and booking a $1 profit.
By repeating this process the shorts can put the stock price in a downward spiral. If there happens to be significant long buying, then the shorts draw from their reserve of “strategic fails-to-deliver” and flood the market with an avalanche of counterfeit shares that overwhelm the buy side demand. Attack days routinely see eighty percent or more of the shares offered for sale as counterfeit. Company news days are frequently attack days since the news will “mask” the extraordinary high volume. It doesn't matter whether it is good news or bad news.
Flooding the market with shares requires foot soldiers to swamp the market with counterfeit shares. An off-shore hedge fund devised a remarkably effective incentive program to motivate the traders at certain broker dealers. Each trader was given a debit card to a bank account that only he could access. The trader's performance was tallied, and, based upon the number of shares moved and the other “success” parameters, the hedge fund would wire money into the bank account daily. At the end of each day, the traders went to an ATM and drew out their bribe. Instant gratification.
Global Links Corporation is an example of how wholesale counterfeiting of shares will decimate a company's stock price. Global Links is a company that provides computer services to the real estate industry. By early 2005, their stock price had dropped to a fraction of a cent. At that point, an investor, Robert Simpson, purchased 100%+ of Global Links' 1,158,064 issued and outstanding shares. He immediately took delivery of his shares and filed the appropriate forms with the SEC, disclosing he owned all of the company's stock. His total investment was $5205. The share price was $.00434. The day after he acquired all of the company's shares, the volume on the over-the-counter market was 37 million shares. The following day saw 22 million shares change hands — all without Simpson trading a single share. It is possible that the SEC has been conducting a secret investigation, but that would be difficult without the company's involvement. It is more likely the SEC has not done anything about this fraud.
Massive counterfeiting can drive the stock price down in a matter of hours on extremely high volume. This is called “crashing” the stock and a successful “crash” is a one-day drop of twenty-percent or a thirty-five percent drop in a week. In order to make the crash “stick” or make it more effective, it is done concurrently with all or most of the following:
2. Media assault — The shorts, in order to realize their profit, must ultimately purchase real shares at a price much cheaper than what they shorted at. These real shares come from the investing public who panics and sells into the manipulation. Panic is induced with assistance from the financial media.
The shorts have “friendly” reporters with the Dow Jones News Agency, the Wall Street Journal, Barrons, the New York Times, Gannett Publications (USA Today and the Arizona Republic), CNBC and others. The common thread: A number of the “friendly” reporters worked for The Street.com, an Internet advisory service that hedge-fund managers David Rocker and Jim Cramer owned. This alumni association supported the short attack by producing slanted, libelous, innuendo laden stories that disparaged the company, as it was being crashed.
One of the more outrageous stories was a front-page story in USA Today during a short crash of TASER's stock price in June 2005. The story was almost a full page and the reporter concluded that TASER's electrical jolt was the same as an electric chair — proof positive that TASERs did indeed kill innocent people. To reach that conclusion the reporter over estimated the TASER's amperage by a factor of one million times. This “mistake” was made despite a detailed technical briefing by TASER to seven USA Today editors two weeks prior to the story. The explanation “Due to a mathematical error” appeared three days later — after the damage was done to the stock price.
Jim Cramer, in a video-taped interview with The Street.com, best described the media function:
When (shorting) ... The hedge fund mode is to not do anything remotely truthful, because the truth is so against your view, (so the hedge funds) create a new 'truth' that is development of the fiction… you hit the brokerage houses with a series of orders (a short down ladder that pushes the price down), then we go to the press. You have a vicious cycle down — it's a pretty good game.
This interview, which is more like a confession, was never supposed to get on the air, however, it somehow ended up on YouTube. Cramer and The Street.com have made repeated efforts, with some success, to get it taken off of YouTube.
3. Analyst Reports — Some alleged independent analysts were actually paid by the shorts to write slanted negative ratings reports. The reports, which were represented as being independent, were ghost written by the shorts and disseminated to coincide with a short attack. There is congressional testimony in the matter of Gradiant Analytic and Rocker Partners that expands upon this. These libelous reports would then become a story in the aforementioned “friendly” media. All were designed to panic small investors into selling their stock into the manipulation.
4. Planting moles in target companies — The shorts plant “moles” inside target companies. The moles can be as high as directors or as low as janitors. They steal confidential information, which is fed to the shorts who may feed it to the friendly media. The information may not be true, may be out of context, or the stolen documents may be altered. Things that are supposed to be confidential, like SEC preliminary inquiries, end up as front-page news with the short-friendly media.
5. Frivolous SEC investigations — The shorts “leak” tips to the SEC about “corporate malfeasance” by the target company. The SEC, which can take months processing Freedom of Information Act requests, swoops in as the supposed “confidential inquiry” is leaked to the short media.
The plethora of corporate rules means the SEC may ultimately find minor transgressions or there may be no findings. Occasionally they do uncover an Enron, but the initial leak can be counted on to drive the stock price down by twenty-five percent. The announcement of no or little findings comes months later, but by then the damage that has been done to the stock price is irreversible. The San Francisco office of the SEC appears to be particularly close to the short community.
6. Class Action lawsuits — Based upon leaked stories of SEC investigations or other media exposes, a handful of law firms immediately file class-action shareholder suits. Milberg Weiss, before they were disbanded as a result of a Justice Department investigation, could be counted on to file a class-action suit against a company that was under short attack. Allegations of accounting improprieties that were made in the complaint would be reported as being the truth by the short friendly media, again causing panic among small investors.
7. Interfering with target company's customers, financings, etc. — If the shorts became aware of clients, customers or financings that the target company was working on, they would call and tell lies or otherwise attempt to persuade the customer to abandon the transaction. Allegedly the shorts have gone so far as to bribe public officials to dissuade them from using a company's product.
8. Pulling margin from long customers — The clearinghouses and broker dealers who finance margin accounts will suddenly pull all long margin availability, citing very transparent reasons for the abrupt change in lending policy. This causes a flood of margin selling, which further drives the stock price down and gets the shorts the cheap long shares that they need to cover.
9. Paid bashers — The shorts will hire paid bashers who “invade” the message boards of the company. The bashers disguise themselves as legitimate investors and try to persuade or panic small investors into selling into the manipulation.
This is not every dirty trick that the shorts use when they are crashing the stock. Almost every victim company experiences most or all of these tactics.
How Pervasive Is This? — At any given point in time more than 100 emerging companies are under attack as described above. This is not to be confused with the day-to-day shorting that occurs in virtually every stock, which is purportedly about thirty percent of the daily volume.
The success rate for short attacks is over ninety percent - a success being defined as putting the company into bankruptcy or driving the stock price to pennies. It is estimated that 1000 small companies have been put out of business by the shorts. Admittedly, not every small company deserves to succeed, but they do deserve a level playing field.
The secrecy that surrounds the shorts, the prime brokers, the DTC and the regulatory agencies makes it impossible to accurately estimate how much money has been stolen from the investing public by these predators, but the total is measured in billions of dollars. The problem is also international in scope.
Who Profits from this Illicit Activity? — The short answer is everyone who participates. Specifically:
1. The shorts — They win over ninety percent of the time. Their return on investment is enormous because they don't put any capital up when they sell short — they get cash from the sale delivered to their account. As long as the stock price remains under their short sale price, it is all profit on no investment.
2. The prime brokers — The shorts need the prime brokers to aid in counterfeiting shares, which is the cornerstone of the fraud. Not only do the prime brokers get sales commissions and interest on margin accounts, they charge the shorts “interest” on borrowed shares. This can be as high as five percent per week. The prime brokers allegedly make eight to ten billion dollars a year from their short stock lend program. The prime brokers also actively short the victim companies, making large trading profits.
3. The DTC — A significant amount of the counterfeiting occurs at the DTC level. They charge the shorts “interest” on borrowed shares, whether it is a legitimate stock borrow or counterfeit shares, as is the case in a vast majority of shares of a company under attack. The amount of profit that the DTC receives is unknown because it is a private company owned by the prime brokers
The Cover Up — The securities industry, certain “respected” members of corporate America who like the profits from illegal shorting, certain criminal elements and our federal government do not want the public to become aware of this problem.
The reason for the cover up is money.
Everyone, including our elected officials, gets lots of money. Consequently there is an active campaign to keep a lid on information. The denial about these illegal practices comes from the industry, the DTC, the SEC and certain members of Congress. They are always delivered in blanket generalities. If indeed there is no problem, as they claim, then why don't they show us the evidence instead of actively and aggressively fighting or deflecting every attempt at obtaining information that is easily accessible for them and impossible for companies and investors? Accusers are counter attacked as being sour-grapes losers, lunatics or opportunistic lawyers trying to unjustly enrich themselves. Death threats are not an unheard of occurrence, although it doesn't appear that anyone has been “whacked” so far.
The securities industry counters with a campaign of misinformation. For example, they proudly pointed out that only one percent of the dollar volume of listed shares are fails-to-deliver. What they don't mention:
* that the fails-to-deliver are concentrated in companies being attacked
* for companies under attack, for every disclosed fail-to-deliver there maybe ten to forty times that number of undisclosed counterfeit shares
* companies under attack have seen their stock price depressed to a small fraction of the price of an average share, therefore the fails-to-deliver as a percentage of number of shares is considerably higher than as a percentage of dollar volume
* the examples cited are limited to listed companies, but much of the abuse occurs in the over the counter market, regional exchanges and on unregulated foreign exchanges that allow naked shorting of American companies, who are not even aware they are traded on the foreign exchanges.
Why does this continue to happen? It is no accident that the most pervasive financial fraud in the history of this country continues unabated. The securities industry advances its agenda on multiple fronts:
1. The truth about counterfeiting remains locked away with the perpetrators of the fraud. The prime brokers, hedge funds, the SEC and the DTC are shrouded in secrecy. They actively and aggressively resist requests for the truth, be it with a subpoena or otherwise. Congressional subpoenas are treated with almost as much disdain as civil subpoenas.
2. The body of securities law at the federal level is so stacked in favor of the industry that it is almost impossible to successfully sue for securities fraud in federal court.
For example, in a normal fraud case, a complaint can be filed based upon “information and belief” that a fraud has been committed. The court then allows the plaintiff to subpoena evidence and depose witnesses, including the defendants. From this discovery, the plaintiff then attempts to prove his case.
Federal securities fraud cases can't be filed based upon “information and belief”; you must have evidence first in order to not have the complaint immediately dismissed for failure to state a cause of action. This information is not available from the defendants (see above) without subpoenas, but you can't issue a subpoena because the case gets dismissed before discovery is opened.
This is only one example of the terrible inequities that exist in federal securities law.
3. The SEC is supposed to protect the investing public from Wall Street predators. While the vast majority of SEC staffers are underpaid, overworked, honest civil servants, the top echelons of the SEC frequently end up in high-paying Wall Street jobs. The five-person Board of Governors, who oversee the SEC, is dominated by the industry. The governors are presidential appointees and the industry usually fills three slots, frequently including the chairmanship.
4. For those rare occasions when the SEC prosecutes an industry insider, the cases almost never go to a judgment or a criminal conviction. The securities company settles for a fine and no finding of guilt. The fine, which may seem like a large sum, is insignificant in the context of an industry that earned 35 billion dollars in 2006. Fines, settlements and legal expenses are just a cost of doing business for Wall Street.
5. The root cause of the impossibly skewed federal laws and the ineffectiveness of the SEC and other regulatory bodies rests squarely with our elected officials. The securities industry contributes heavily to both parties at the presidential and congressional levels. As long as the public is passive about securities reform, our elected officials are happy to take the money, which at the federal level was 65 million dollars in 2006.
The Democrats swept into power with a promise of ethics reform. Their majority in congress allowed Christopher Dodd (D-CT) to ascend to the chairmanship of the Senate Banking Committee, which regulates the securities industry. His largest single contributor ($175,400) in the first quarter of 2007 was (employees of) SAC Capital, a very aggressive short hedge fund. Are we surprised that Dodd has opposed additional regulation of hedge funds. They are virtually unregulated.
6. Some states have their own securities laws and their own enforcement arm. Certain states including Connecticut, Illinois, Utah, Louisiana and others, have begun active enforcement of their own laws. The state laws are not nearly as pro industry as federal laws and plaintiffs are having success.
To thwart this, the industry with the support of the SEC, is attempting to have the federal court system and federal agencies, be the sole venue for securities matters. The SEC is working hand in hand with the industry to advance this theory of federal preemption, which would put all securities matters under federal law, all litigation in federal courts, and all enforcement with the SEC.
The following are recent examples of how the SEC is advancing the industry agenda:
* The San Francisco office of the SEC issued subpoenas to various short friendly media outlets after congressional hearings about David Rocker and Gradient Analytic. This investigation into the media involvement with the shorts was ended by the chairman of the SEC, Christopher Cox, who withdrew the subpoenas, apparently concluding that the First Amendment right to free speech protected participants in an alleged stock manipulation. Jim Cramer ripped up his subpoena on his television show, thumbing his nose at the SEC.
* In early 2007, the SEC completely exonerated Gradient, citing Gradient's First Amendment rights.
* The Nevada Supreme court heard a case captioned Nanopierce vs. DTCC. Nanopierce is an emerging company that was attacked by the shorts and subjected to massive counterfeiting of their stock by the DTCC. This state court case is close to opening discovery against the DTCC, so the industry is attempting to kill the lawsuit by arguing it should be in federal court — where it will be DOA. The SEC showed up as a friend of the defendant DTCC, and filed a brief in support of the DTCC efforts to remove the case to the federal court system.
* Both houses of the Utah legislature passed a bill that required daily disclosure of fails-to-deliver, including identifying specific companies and the specific broker dealer positions in that company. The bill also outlawed naked shorting of companies domiciled in Utah. The industry threatened litigation based upon federal preemption and backed the state down. The bill was not signed into law.
* A bill was introduced to the Arizona legislature that required disclosure similar to the Utah bill, but without the illegal naked shorting provision. This is the same information that the DTC confidentially provides to the SEC. Certain prime broker's lobbying effort allegedly managed to get the bill killed in committee. The industries efforts to curtail state authority, is an effort to draw all securities matters under the federal umbrella, where small investors don't have a chance of obtaining justice.
* In February 2007 the SEC determined that the hedge fund industry did not require any additional regulation — they are virtually unregulated. This may be the height of arrogance.
Sources — Information used was obtained from public records; the SEC; the Leslie Boni Report to the SEC on shorting; evidence and testimony in court proceedings; conversations with attorneys who are involved in securities litigation; former SEC employees; conversations with management of victim companies; and first hand experience as investors in companies that have suffered short attacks. This web site is sponsored by Citizens for Securities Reform.
What to Do? — Many of our elected officials at the federal and state level do not understand most of what is contained in this paper. They must come to understand this fraud, and, more importantly, understand that their constituents are angry.
Pass this information to everyone you know — put it in the public conscience. Then the citizenry needs to engage in a massive letter-writing campaign. Feel free to attach this report. Make sure your elected officials, at the federal level and state level know how you feel. Ultimately, votes in the home district will trump money from the outside.
So you say you don't like NITE all that much ?? Well if your looking to get even with them for something they did to you then take a minute and look at telvue.com. Some of the worlds finest digital storage servers. 8 million in the float. TEVE is over the counter. Fully reporting and a place where I have gone to the shareholders meeting for many years. This is our year.
Come strike a blow for victory. 100 shares OK. We are at 0.14. And two buys at bid and we will be at 0.50. Take a look. It does not cost to watch. We make a profit this quarter and away we go.
from finra .... page 8
http://www.finra.org/web/groups/industry/@ip/@enf/@da/documents/disciplinaryactions/p121119.pdf
gee great job *finra* .. sheesh that 112k+ *fine*
really hurts NITE .. eh? yeah what did NITE write
off last year in their annual for FTD'S?
truly what a mucked up system in place
who is the hen and who is the fox
seriously us entities have become a world wide *joke*
open to all sorts of exploitation .. try *getting* current
with the technology options actually available today and
make *cross* checks between the sec/finra and the pcaob
*mandatory* .. don't forget to take the time for *commentary*
christ
Knight EquityMarkets, L.P. (CRD #38599, Jersey City, New Jersey) submitted a Letter of
Acceptance,Waiver and Consent in which the firm was censured and fined $112,500.
Without admitting or denying the findings, the firm consented to the described
sanctions and to the entry of findings that it transmitted ROEs to OATS that OATS
rejected for context or syntax errors and failed to repair some of the rejected ROEs, and
transmitted reports to OATS that were submitted with an improper exception code, and
failed to indicate that transactions were short sales. The findings stated that the firm
transmitted Execution Reports to OATS that contained inaccurate branch sequence
numbers. The findings also stated that the firm failed to report to the NMC the correct
symbol indicating that transactions in reportable securities were short sales and
whether the transactions were buy, sell, sell short or cross. The findings also included
that the firmexecuted short sale orders and failed to properly mark the orders as short.
FINRA found that the firm failed to report to the NASD/NASDAQ Trade Reporting
Facility (NNTRF) the correct symbol indicating the contra correspondent’s capacity for
transactions in reportable securities. (FINRA Case #2006004129901)
--
4kids
all jmo
Channel Trend Inc. upgrades KNIGHT CAP GROUP INC from MOST UNFAVORABLE to UNFAVORABLE.
INVESTARS ANALYST ACTIONS - PRIVATE – 07/05/2010
wow .. that's an impressive *call* from a cohort :)
--
i see kcg formerly known as nite .. is still sucking wind
as the entire world awaits what is what .. gee who else
got a well's notice in 2009?
---
Detailed Quote:KCG
KNIGHT CAPITAL GROUP, INC.
14.24-0.16 (-1.11%)AS OF 4:02:27PM ET 07/12/2010
Last Trade 14.24
Trade Time 4:02:27PM ET
Last Trade Exchange NYSE
Today's Change -0.16
Today's % Change -1.11%
Open 14.43
Day High 14.4400
Day Low 14.15
Previous Close Price
07/09/2010 14.40
52-Week High
10/14/2009 23.11
52-Week Low
07/06/2010 13.25
Volume 541,049
Average Volume (10-Day) 1,250,367
Average Volume (90-Day) 2,162,838
--
4kids
all jmo
NITE 1411 - HESG Answer - Shareholders Will Report Alleged Abusive Naked Short Selling Activity Starting Today July 5, 2010.
more possible answer...
The markets and the SROs are primarily responsible for the surveillance and enforcement of trading activity pursuant to their rules. The SEC, however, independently or in conjunction with the SROs and other regulatory authorities, actively investigates and prosecutes violations of the federal securities laws.
The SEC takes information alleging violations of the federal securities laws very seriously. If you have specific enforcement-related information, please send it in an email to enforcement@sec.gov. Please note, however, the SEC will neither confirm nor deny the existence of an investigation unless, and until, it becomes a matter of public record as the result of a court action or administrative proceeding. As you may also be aware, SEC investigations are conducted on a non-public and confidential basis to help assure the integrity of the investigative process. See http://www.sec.gov/investor/pubs/howoiea.htm for more information on how the Commission handles complaints.
VII. Regulation SHO – Releases and Other Guidance
The final adopting release for Regulation SHO and other key documents relating to short sale regulation, such as the "Frequently Asked Questions Regarding Regulation SHO" published by the Staff of the Division of Market Regulation, are available on the Commission's website at: http://www.sec.gov/spotlight/shortsales.htm.
The NasdaqTrader has also issued guidance on Regulation SHO through a Frequently Asked Questions release on its website at: http://www.nasdaqtrader.com/trader/hottopics/RegSHOFAQs.pdf.
VIII. Who Do I Contact If I Have Questions about Regulation SHO?
Individual investors who have comments or information should feel free to contact the SEC's Office of Investor Education and Assistance at 1-800-SEC-0330 or (202) 942-7040. Investors can also file complaints at www.sec.gov/complaint.shtml.
SETTLEMENT DATE CUSIP SYMBOL QUANTITY (FAILS) DESCRIPTION PRICE
Quote:20040401 42223A100 HESG 122490 HEALTH SCIENCES GROUP INC 1
20040402 42223A100 HESG 122790 HEALTH SCIENCES GROUP INC 1
20040405 42223A100 HESG 126289 HEALTH SCIENCES GROUP INC 1
20040406 42223A100 HESG 94290 HEALTH SCIENCES GROUP INC 1
20040407 42223A100 HESG 106789 HEALTH SCIENCES GROUP INC 1
20040408 42223A100 HESG 106290 HEALTH SCIENCES GROUP INC 1
20040412 42223A100 HESG 108190 HEALTH SCIENCES GROUP INC 1
20040413 42223A100 HESG 108190 HEALTH SCIENCES GROUP INC 1
20040414 42223A100 HESG 111839 HEALTH SCIENCES GROUP INC 1
20040415 42223A100 HESG 119509 HEALTH SCIENCES GROUP INC 1
20040416 42223A100 HESG 119659 HEALTH SCIENCES GROUP INC 1
20040419 42223A100 HESG 120489 HEALTH SCIENCES GROUP INC 1
20040420 42223A100 HESG 123399 HEALTH SCIENCES GROUP INC 1
20040421 42223A100 HESG 130869 HEALTH SCIENCES GROUP INC 1
20040422 42223A100 HESG 121769 HEALTH SCIENCES GROUP INC 1
20040423 42223A100 HESG 135749 HEALTH SCIENCES GROUP INC 1
20040426 42223A100 HESG 142949 HEALTH SCIENCES GROUP INC 1
20040427 42223A100 HESG 144630 HEALTH SCIENCES GROUP INC 1
20040428 42223A100 HESG 139729 HEALTH SCIENCES GROUP INC 1
20040429 42223A100 HESG 153729 HEALTH SCIENCES GROUP INC 1
20040430 42223A100 HESG 153100 HEALTH SCIENCES GROUP INC 1
20040503 42223A100 HESG 152100 HEALTH SCIENCES GROUP INC 1
20040504 42223A100 HESG 148200 HEALTH SCIENCES GROUP INC 1
20040505 42223A100 HESG 154750 HEALTH SCIENCES GROUP INC 1
20040506 42223A100 HESG 153500 HEALTH SCIENCES GROUP INC 1
20040507 42223A100 HESG 150972 HEALTH SCIENCES GROUP INC 1
20040510 42223A100 HESG 157172 HEALTH SCIENCES GROUP INC 1
20040511 42223A100 HESG 162042 HEALTH SCIENCES GROUP INC 1
20040512 42223A100 HESG 166042 HEALTH SCIENCES GROUP INC 1
20040513 42223A100 HESG 166542 HEALTH SCIENCES GROUP INC 1
20040514 42223A100 HESG 167042 HEALTH SCIENCES GROUP INC 1
20040517 42223A100 HESG 180422 HEALTH SCIENCES GROUP INC 1
20040518 42223A100 HESG 175172 HEALTH SCIENCES GROUP INC 1
20040519 42223A100 HESG 174072 HEALTH SCIENCES GROUP INC 1
20040520 42223A100 HESG 171348 HEALTH SCIENCES GROUP INC 1
20040521 42223A100 HESG 168348 HEALTH SCIENCES GROUP INC 1
20040524 42223A100 HESG 171348 HEALTH SCIENCES GROUP INC 1
20040525 42223A100 HESG 169277 HEALTH SCIENCES GROUP INC 1
20040526 42223A100 HESG 163847 HEALTH SCIENCES GROUP INC 1
20040527 42223A100 HESG 169547 HEALTH SCIENCES GROUP INC 1
20040528 42223A100 HESG 162678 HEALTH SCIENCES GROUP INC 1
20040601 42223A100 HESG 154395 HEALTH SCIENCES GROUP INC 1
20040602 42223A100 HESG 153295 HEALTH SCIENCES GROUP INC 1
20040603 42223A100 HESG 143895 HEALTH SCIENCES GROUP INC 1
20040604 42223A100 HESG 151533 HEALTH SCIENCES GROUP INC 1
20040607 42223A100 HESG 149620 HEALTH SCIENCES GROUP INC 1
20040608 42223A100 HESG 153120 HEALTH SCIENCES GROUP INC 1
20040609 42223A100 HESG 153062 HEALTH SCIENCES GROUP INC 1
20040610 42223A100 HESG 133257 HEALTH SCIENCES GROUP INC 1
20040611 42223A100 HESG 128757 HEALTH SCIENCES GROUP INC 1
20040614 42223A100 HESG 132257 HEALTH SCIENCES GROUP INC 1
20040615 42223A100 HESG 134757 HEALTH SCIENCES GROUP INC 1
20040616 42223A100 HESG 129757 HEALTH SCIENCES GROUP INC 1
20040617 42223A100 HESG 133540 HEALTH SCIENCES GROUP INC 1
20040618 42223A100 HESG 132018 HEALTH SCIENCES GROUP INC 1
20040621 42223A100 HESG 132018 HEALTH SCIENCES GROUP INC 1
20040622 42223A100 HESG 130452 HEALTH SCIENCES GROUP INC 1
20040623 42223A100 HESG 128514 HEALTH SCIENCES GROUP INC 1
20040624 42223A100 HESG 131214 HEALTH SCIENCES GROUP INC 1
20040625 42223A100 HESG 129513 HEALTH SCIENCES GROUP INC 1
20040628 42223A100 HESG 115243 HEALTH SCIENCES GROUP INC 1
20040629 42223A100 HESG 121115 HEALTH SCIENCES GROUP INC 1
20040630 42223A100 HESG 124115 HEALTH SCIENCES GROUP INC 1
20040701 42223A100 HESG 122115 HEALTH SCIENCES GROUP INC 1
20040702 42223A100 HESG 125435 HEALTH SCIENCES GROUP INC 1
20040706 42223A100 HESG 125615 HEALTH SCIENCES GROUP INC 1
20040707 42223A100 HESG 125115 HEALTH SCIENCES GROUP INC 1
20040708 42223A100 HESG 126265 HEALTH SCIENCES GROUP INC 1
20040709 42223A100 HESG 129225 HEALTH SCIENCES GROUP INC 1
20040712 42223A100 HESG 127198 HEALTH SCIENCES GROUP INC 1
20040713 42223A100 HESG 125398 HEALTH SCIENCES GROUP INC 1
20040714 42223A100 HESG 127098 HEALTH SCIENCES GROUP INC 1
20040715 42223A100 HESG 125098 HEALTH SCIENCES GROUP INC 1
20040716 42223A100 HESG 120098 HEALTH SCIENCES GROUP INC 1
20040719 42223A100 HESG 113098 HEALTH SCIENCES GROUP INC 1
20040720 42223A100 HESG 116598 HEALTH SCIENCES GROUP INC 1
20040721 42223A100 HESG 120598 HEALTH SCIENCES GROUP INC 1
20040722 42223A100 HESG 127498 HEALTH SCIENCES GROUP INC 1
20040723 42223A100 HESG 124498 HEALTH SCIENCES GROUP INC 1
20040726 42223A100 HESG 123798 HEALTH SCIENCES GROUP INC 1
20040727 42223A100 HESG 125298 HEALTH SCIENCES GROUP INC 1
20040728 42223A100 HESG 126234 HEALTH SCIENCES GROUP INC 1
20040729 42223A100 HESG 118734 HEALTH SCIENCES GROUP INC 1
20040730 42223A100 HESG 144234 HEALTH SCIENCES GROUP INC 1
20040802 42223A100 HESG 147234 HEALTH SCIENCES GROUP INC 1
20040803 42223A100 HESG 115324 HEALTH SCIENCES GROUP INC 1
20040804 42223A100 HESG 119824 HEALTH SCIENCES GROUP INC 1
20040805 42223A100 HESG 116674 HEALTH SCIENCES GROUP INC 1
20040806 42223A100 HESG 118538 HEALTH SCIENCES GROUP INC 1
20040810 42223A100 HESG 117738 HEALTH SCIENCES GROUP INC 1
20040811 42223A100 HESG 125238 HEALTH SCIENCES GROUP INC 1
20040812 42223A100 HESG 123238 HEALTH SCIENCES GROUP INC 1
20040813 42223A100 HESG 121238 HEALTH SCIENCES GROUP INC 1
20040816 42223A100 HESG 118738 HEALTH SCIENCES GROUP INC 1
20040817 42223A100 HESG 113197 HEALTH SCIENCES GROUP INC 1
20040818 42223A100 HESG 111997 HEALTH SCIENCES GROUP INC 1
20040819 42223A100 HESG 118997 HEALTH SCIENCES GROUP INC 1
20040820 42223A100 HESG 122597 HEALTH SCIENCES GROUP INC 1
20040823 42223A100 HESG 123453 HEALTH SCIENCES GROUP INC 1
20040824 42223A100 HESG 118153 HEALTH SCIENCES GROUP INC 1
20040825 42223A100 HESG 119753 HEALTH SCIENCES GROUP INC 1
20040826 42223A100 HESG 110047 HEALTH SCIENCES GROUP INC 1
20040827 42223A100 HESG 107047 HEALTH SCIENCES GROUP INC 1
20040830 42223A100 HESG 107047 HEALTH SCIENCES GROUP INC 1
20040831 42223A100 HESG 107047 HEALTH SCIENCES GROUP INC 1
20040901 42223A100 HESG 111509 HEALTH SCIENCES GROUP INC 1
20040902 42223A100 HESG 116509 HEALTH SCIENCES GROUP INC 1
20040903 42223A100 HESG 116509 HEALTH SCIENCES GROUP INC 1
20040907 42223A100 HESG 117266 HEALTH SCIENCES GROUP INC 1
20040908 42223A100 HESG 119609 HEALTH SCIENCES GROUP INC 1
20040909 42223A100 HESG 118609 HEALTH SCIENCES GROUP INC 1
20040910 42223A100 HESG 116847 HEALTH SCIENCES GROUP INC 1
20040913 42223A100 HESG 114498 HEALTH SCIENCES GROUP INC 1
20040914 42223A100 HESG 115025 HEALTH SCIENCES GROUP INC 1
20040915 42223A100 HESG 112940 HEALTH SCIENCES GROUP INC 1
20040916 42223A100 HESG 110947 HEALTH SCIENCES GROUP INC 1
20040917 42223A100 HESG 125397 HEALTH SCIENCES GROUP INC 1
20040920 42223A100 HESG 120897 HEALTH SCIENCES GROUP INC 1
20040921 42223A100 HESG 116532 HEALTH SCIENCES GROUP INC 1
20040922 42223A100 HESG 115532 HEALTH SCIENCES GROUP INC 1
20040923 42223A100 HESG 106510 HEALTH SCIENCES GROUP INC 1
20040924 42223A100 HESG 109510 HEALTH SCIENCES GROUP INC 1
20040927 42223A100 HESG 117310 HEALTH SCIENCES GROUP INC 1
20040928 42223A100 HESG 111960 HEALTH SCIENCES GROUP INC 1
20040929 42223A100 HESG 122982 HEALTH SCIENCES GROUP INC 1
20040930 42223A100 HESG 115104 HEALTH SCIENCES GROUP INC 1
20041001 42223A100 HESG 124904 HEALTH SCIENCES GROUP INC 1
20041004 42223A100 HESG 125704 HEALTH SCIENCES GROUP INC 1
20041005 42223A100 HESG 125204 HEALTH SCIENCES GROUP INC 1
20041006 42223A100 HESG 125904 HEALTH SCIENCES GROUP INC 1
20041007 42223A100 HESG 124966 HEALTH SCIENCES GROUP INC 1
20041008 42223A100 HESG 122866 HEALTH SCIENCES GROUP INC 1
20041012 42223A100 HESG 120366 HEALTH SCIENCES GROUP INC 1
20041013 42223A100 HESG 117478 HEALTH SCIENCES GROUP INC 1
20041014 42223A100 HESG 128128 HEALTH SCIENCES GROUP INC 1
20041015 42223A100 HESG 128128 HEALTH SCIENCES GROUP INC 1
20041018 42223A100 HESG 182628 HEALTH SCIENCES GROUP INC 1
20041019 42223A100 HESG 118286 HEALTH SCIENCES GROUP INC 1
20041020 42223A100 HESG 127435 HEALTH SCIENCES GROUP INC 1
20041021 42223A100 HESG 123475 HEALTH SCIENCES GROUP INC 1
20041022 42223A100 HESG 125635 HEALTH SCIENCES GROUP INC 1
20041025 42223A100 HESG 123675 HEALTH SCIENCES GROUP INC 1
20041026 42223A100 HESG 124675 HEALTH SCIENCES GROUP INC 1
20041027 42223A100 HESG 121690 HEALTH SCIENCES GROUP INC 1
20041028 42223A100 HESG 117090 HEALTH SCIENCES GROUP INC 1
20041029 42223A100 HESG 120175 HEALTH SCIENCES GROUP INC 1
20041101 42223A100 HESG 86375 HEALTH SCIENCES GROUP INC 1
20041102 42223A100 HESG 96575 HEALTH SCIENCES GROUP INC 1
20041105 42223A100 HESG 141094 HEALTH SCIENCES GROUP INC 1
20041108 42223A100 HESG 140094 HEALTH SCIENCES GROUP INC 1
20041109 42223A100 HESG 139094 HEALTH SCIENCES GROUP INC 1
20041110 42223A100 HESG 142244 HEALTH SCIENCES GROUP INC 1
20041112 42223A100 HESG 139594 HEALTH SCIENCES GROUP INC 1
20041115 42223A100 HESG 146984 HEALTH SCIENCES GROUP INC 1
20041116 42223A100 HESG 213296 HEALTH SCIENCES GROUP INC 1
20041117 42223A100 HESG 213897 HEALTH SCIENCES GROUP INC 1
20041118 42223A100 HESG 220957 HEALTH SCIENCES GROUP INC 1
20041119 42223A100 HESG 203057 HEALTH SCIENCES GROUP INC 1
20041122 42223A100 HESG 200357 HEALTH SCIENCES GROUP INC 1
20041123 42223A100 HESG 221007 HEALTH SCIENCES GROUP INC 1
20041124 42223A100 HESG 220850 HEALTH SCIENCES GROUP INC 1
20041126 42223A100 HESG 218350 HEALTH SCIENCES GROUP INC 1
20041129 42223A100 HESG 175450 HEALTH SCIENCES GROUP INC 1
20041130 42223A100 HESG 191310 HEALTH SCIENCES GROUP INC 1
20041201 42223A100 HESG 192560 HEALTH SCIENCES GROUP INC 1
20041202 42223A100 HESG 208193 HEALTH SCIENCES GROUP INC 1
20041203 42223A100 HESG 212513 HEALTH SCIENCES GROUP INC 1
20041206 42223A100 HESG 207513 HEALTH SCIENCES GROUP INC 1
20041207 42223A100 HESG 198013 HEALTH SCIENCES GROUP INC 1
20041208 42223A100 HESG 205559 HEALTH SCIENCES GROUP INC 1
20041209 42223A100 HESG 196981 HEALTH SCIENCES GROUP INC 1
20041210 42223A100 HESG 185991 HEALTH SCIENCES GROUP INC 1
20041213 42223A100 HESG 185547 HEALTH SCIENCES GROUP INC 1
20041214 42223A100 HESG 201164 HEALTH SCIENCES GROUP INC 1
20041215 42223A100 HESG 196574 HEALTH SCIENCES GROUP INC 1
20041216 42223A100 HESG 241984 HEALTH SCIENCES GROUP INC 1
20041217 42223A100 HESG 239284 HEALTH SCIENCES GROUP INC 1
20041220 42223A100 HESG 226019 HEALTH SCIENCES GROUP INC 1
20041221 42223A100 HESG 227949 HEALTH SCIENCES GROUP INC 1
20041222 42223A100 HESG 236249 HEALTH SCIENCES GROUP INC 1
20041223 42223A100 HESG 233749 HEALTH SCIENCES GROUP INC 1
20041227 42223A100 HESG 233749 HEALTH SCIENCES GROUP INC 1
20041228 42223A100 HESG 231749 HEALTH SCIENCES GROUP INC 1
20041229 42223A100 HESG 258249 HEALTH SCIENCES GROUP INC 1
20041230 42223A100 HESG 259249 HEALTH SCIENCES GROUP INC 1
20041231 42223A100 HESG 260929 HEALTH SCIENCES GROUP INC 1
20050103 42223A100 HESG 266371 HEALTH SCIENCES GROUP INC 1
20050104 42223A100 HESG 234371 HEALTH SCIENCES GROUP INC 1
20050105 42223A100 HESG 195129 HEALTH SCIENCES GROUP INC 1
20050106 42223A100 HESG 223387 HEALTH SCIENCES GROUP INC 1
20050107 42223A100 HESG 223088 HEALTH SCIENCES GROUP INC 1
20050110 42223A100 HESG 223088 HEALTH SCIENCES GROUP INC 1
20050111 42223A100 HESG 220712 HEALTH SCIENCES GROUP INC 1
20050112 42223A100 HESG 225712 HEALTH SCIENCES GROUP INC 1
20050113 42223A100 HESG 173888 HEALTH SCIENCES GROUP INC 1
20050114 42223A100 HESG 169198 HEALTH SCIENCES GROUP INC 1
20050118 42223A100 HESG 170198 HEALTH SCIENCES GROUP INC 1
20050119 42223A100 HESG 166698 HEALTH SCIENCES GROUP INC 1
20050120 42223A100 HESG 169065 HEALTH SCIENCES GROUP INC 1
20050121 42223A100 HESG 153928 HEALTH SCIENCES GROUP INC 1
20050124 42223A100 HESG 166928 HEALTH SCIENCES GROUP INC 1
20050125 42223A100 HESG 184128 HEALTH SCIENCES GROUP INC 1
20050126 42223A100 HESG 209643 HEALTH SCIENCES GROUP INC 1
20050127 42223A100 HESG 200718 HEALTH SCIENCES GROUP INC 1
20050128 42223A100 HESG 200935 HEALTH SCIENCES GROUP INC 1
20050131 42223A100 HESG 210390 HEALTH SCIENCES GROUP INC 1
20050201 42223A100 HESG 213652 HEALTH SCIENCES GROUP INC 1
20050202 42223A100 HESG 215113 HEALTH SCIENCES GROUP INC 1
20050203 42223A100 HESG 192843 HEALTH SCIENCES GROUP INC 1
20050204 42223A100 HESG 142024 HEALTH SCIENCES GROUP INC 1
20050207 42223A100 HESG 386426 HEALTH SCIENCES GROUP INC 1
20050208 42223A100 HESG 438626 HEALTH SCIENCES GROUP INC 1
20050209 42223A100 HESG 128856 HEALTH SCIENCES GROUP INC 1
20050210 42223A100 HESG 123824 HEALTH SCIENCES GROUP INC 1
20050211 42223A100 HESG 100581 HEALTH SCIENCES GROUP INC 1
20050214 42223A100 HESG 80686 HEALTH SCIENCES GROUP INC 1
20050215 42223A100 HESG 72506 HEALTH SCIENCES GROUP INC 1
20050216 42223A100 HESG 70781 HEALTH SCIENCES GROUP INC 1
20050217 42223A100 HESG 190806 HEALTH SCIENCES GROUP INC 1
20050218 42223A100 HESG 243106 HEALTH SCIENCES GROUP INC 1
20050222 42223A100 HESG 251076 HEALTH SCIENCES GROUP INC 1
20050223 42223A100 HESG 262100 HEALTH SCIENCES GROUP INC 1
20050224 42223A100 HESG 296890 HEALTH SCIENCES GROUP INC 1
20050225 42223A100 HESG 363680 HEALTH SCIENCES GROUP INC 1
20050228 42223A100 HESG 372645 HEALTH SCIENCES GROUP INC 1
20050301 42223A100 HESG 364548 HEALTH SCIENCES GROUP INC 1
20050302 42223A100 HESG 264404 HEALTH SCIENCES GROUP INC 1
20050303 42223A100 HESG 269854 HEALTH SCIENCES GROUP INC 1
20050304 42223A100 HESG 279299 HEALTH SCIENCES GROUP INC 1
20050307 42223A100 HESG 314899 HEALTH SCIENCES GROUP INC 1
20050308 42223A100 HESG 165050 HEALTH SCIENCES GROUP INC 1
20050309 42223A100 HESG 181571 HEALTH SCIENCES GROUP INC 1
20050310 42223A100 HESG 73321 HEALTH SCIENCES GROUP INC 1
20050311 42223A100 HESG 27275 HEALTH SCIENCES GROUP INC 1
20050314 42223A100 HESG 15865 HEALTH SCIENCES GROUP INC 1
20050315 42223A100 HESG 17615 HEALTH SCIENCES GROUP INC 1
20050316 42223A100 HESG 15978 HEALTH SCIENCES GROUP INC 1
20050317 42223A100 HESG 28874 HEALTH SCIENCES GROUP INC 1
20050318 42223A100 HESG 77038 HEALTH SCIENCES GROUP INC 1
20050321 42223A100 HESG 42829 HEALTH SCIENCES GROUP INC 1
20050322 42223A100 HESG 30229 HEALTH SCIENCES GROUP INC 1
20050323 42223A100 HESG 49896 HEALTH SCIENCES GROUP INC 1
20050324 42223A100 HESG 153561 HEALTH SCIENCES GROUP INC 1
20050328 42223A100 HESG 221412 HEALTH SCIENCES GROUP INC 1
20050329 42223A100 HESG 72700 HEALTH SCIENCES GROUP INC 1
20050330 42223A100 HESG 181200 HEALTH SCIENCES GROUP INC 1
20050331 42223A100 HESG 197148 HEALTH SCIENCES GROUP INC 1
20050401 42223A100 HESG 188480 HEALTH SCIENCES GROUP INC 1
20050404 42223A100 HESG 164003 HEALTH SCIENCES GROUP INC 1
20050405 42223A100 HESG 156385 HEALTH SCIENCES GROUP INC 1
20050406 42223A100 HESG 152252 HEALTH SCIENCES GROUP INC 1
20050407 42223A100 HESG 147799 HEALTH SCIENCES GROUP INC 1
20050408 42223A100 HESG 159691 HEALTH SCIENCES GROUP INC 1
20050411 42223A100 HESG 163848 HEALTH SCIENCES GROUP INC 1
20050412 42223A100 HESG 149624 HEALTH SCIENCES GROUP INC 1
20050413 42223A100 HESG 151923 HEALTH SCIENCES GROUP INC 1
20050414 42223A100 HESG 181053 HEALTH SCIENCES GROUP INC 1
20050415 42223A100 HESG 173961 HEALTH SCIENCES GROUP INC 1
20050418 42223A100 HESG 177816 HEALTH SCIENCES GROUP INC 1
20050419 42223A100 HESG 155099 HEALTH SCIENCES GROUP INC 1
20050420 42223A100 HESG 119144 HEALTH SCIENCES GROUP INC 1
20050421 42223A100 HESG 182980 HEALTH SCIENCES GROUP INC 1
20050422 42223A100 HESG 212600 HEALTH SCIENCES GROUP INC 1
20050425 42223A100 HESG 214128 HEALTH SCIENCES GROUP INC 1
20050426 42223A100 HESG 312150 HEALTH SCIENCES GROUP INC 1
20050427 42223A100 HESG 306255 HEALTH SCIENCES GROUP INC 1
20050428 42223A100 HESG 323342 HEALTH SCIENCES GROUP INC 1
20050429 42223A100 HESG 310524 HEALTH SCIENCES GROUP INC 1
20050502 42223A100 HESG 339815 HEALTH SCIENCES GROUP INC 1
20050503 42223A100 HESG 367203 HEALTH SCIENCES GROUP INC 1
20050504 42223A100 HESG 391918 HEALTH SCIENCES GROUP INC 1
20050505 42223A100 HESG 414969 HEALTH SCIENCES GROUP INC 1
20050506 42223A100 HESG 406254 HEALTH SCIENCES GROUP INC 1
20050509 42223A100 HESG 402464 HEALTH SCIENCES GROUP INC 1
20050510 42223A100 HESG 255589 HEALTH SCIENCES GROUP INC 1
20050511 42223A100 HESG 226841 HEALTH SCIENCES GROUP INC 1
20050512 42223A100 HESG 258306 HEALTH SCIENCES GROUP INC 1
20050513 42223A100 HESG 256806 HEALTH SCIENCES GROUP INC 1
20050516 42223A100 HESG 261609 HEALTH SCIENCES GROUP INC 1
20050517 42223A100 HESG 222401 HEALTH SCIENCES GROUP INC 1
20050518 42223A100 HESG 229325 HEALTH SCIENCES GROUP INC 1
20050519 42223A100 HESG 244231 HEALTH SCIENCES GROUP INC 1
20050520 42223A100 HESG 201020 HEALTH SCIENCES GROUP INC 1
20050523 42223A100 HESG 223746 HEALTH SCIENCES GROUP INC 1
20050524 42223A100 HESG 359749 HEALTH SCIENCES GROUP INC 1
20050525 42223A100 HESG 396691 HEALTH SCIENCES GROUP INC 1
20050526 42223A100 HESG 359649 HEALTH SCIENCES GROUP INC 1
20050527 42223A100 HESG 380698 HEALTH SCIENCES GROUP INC 1
20050531 42223A100 HESG 316449 HEALTH SCIENCES GROUP INC 1
20050601 42223A100 HESG 319307 HEALTH SCIENCES GROUP INC 1
20050602 42223A100 HESG 269076 HEALTH SCIENCES GROUP INC 1
20050603 42223A100 HESG 290920 HEALTH SCIENCES GROUP INC 1
20050606 42223A100 HESG 147402 HEALTH SCIENCES GROUP INC 1
20050607 42223A100 HESG 141702 HEALTH SCIENCES GROUP INC 1
20050608 42223A100 HESG 164488 HEALTH SCIENCES GROUP INC 1
20050609 42223A100 HESG 168772 HEALTH SCIENCES GROUP INC 1
20050610 42223A100 HESG 164165 HEALTH SCIENCES GROUP INC 1
20050613 42223A100 HESG 163265 HEALTH SCIENCES GROUP INC 1
20050614 42223A100 HESG 123765 HEALTH SCIENCES GROUP INC 1
20050615 42223A100 HESG 58955 HEALTH SCIENCES GROUP INC 1
20050616 42223A100 HESG 59410 HEALTH SCIENCES GROUP INC 1
20050617 42223A100 HESG 60162 HEALTH SCIENCES GROUP INC 1
20050620 42223A100 HESG 30722 HEALTH SCIENCES GROUP INC 1
20050621 42223A100 HESG 64064 HEALTH SCIENCES GROUP INC 1
20050622 42223A100 HESG 40842 HEALTH SCIENCES GROUP INC 1
20050623 42223A100 HESG 35231 HEALTH SCIENCES GROUP INC 1
20050624 42223A100 HESG 28827 HEALTH SCIENCES GROUP INC 1
20050627 42223A100 HESG 11570 HEALTH SCIENCES GROUP INC 1
20050707 42223A100 HESG 12310 HEALTH SCIENCES GROUP INC 1
20050713 42223A100 HESG 39891 HEALTH SCIENCES GROUP INC 1
20050714 42223A100 HESG 14571 HEALTH SCIENCES GROUP INC 1
20050715 42223A100 HESG 10622 HEALTH SCIENCES GROUP INC 1
20050725 42223A100 HESG 27522 HEALTH SCIENCES GROUP INC 1
20050726 42223A100 HESG 23859 HEALTH SCIENCES GROUP INC 1
20050727 42223A100 HESG 22017 HEALTH SCIENCES GROUP INC 1
20050728 42223A100 HESG 16570 HEALTH SCIENCES GROUP INC 1
20050729 42223A100 HESG 17000 HEALTH SCIENCES GROUP INC 1
20050801 42223A100 HESG 11270 HEALTH SCIENCES GROUP INC 1
20050802 42223A100 HESG 10533 HEALTH SCIENCES GROUP INC 1
20050803 42223A100 HESG 56505 HEALTH SCIENCES GROUP INC 1
20050804 42223A100 HESG 82662 HEALTH SCIENCES GROUP INC 1
20050805 42223A100 HESG 136670 HEALTH SCIENCES GROUP INC 1
20050808 42223A100 HESG 157615 HEALTH SCIENCES GROUP INC 1
20050809 42223A100 HESG 206180 HEALTH SCIENCES GROUP INC 1
20050810 42223A100 HESG 205795 HEALTH SCIENCES GROUP INC 1
20050811 42223A100 HESG 203912 HEALTH SCIENCES GROUP INC 1
20050812 42223A100 HESG 128395 HEALTH SCIENCES GROUP INC 1
20050815 42223A100 HESG 146035 HEALTH SCIENCES GROUP INC 1
20050816 42223A100 HESG 139207 HEALTH SCIENCES GROUP INC 1
20050817 42223A100 HESG 142559 HEALTH SCIENCES GROUP INC 1
20050818 42223A100 HESG 144408 HEALTH SCIENCES GROUP INC 1
20050819 42223A100 HESG 132537 HEALTH SCIENCES GROUP INC 1
20050822 42223A100 HESG 131732 HEALTH SCIENCES GROUP INC 1
20050823 42223A100 HESG 131972 HEALTH SCIENCES GROUP INC 1
20050824 42223A100 HESG 129795 HEALTH SCIENCES GROUP INC 1
20050825 42223A100 HESG 139124 HEALTH SCIENCES GROUP INC 1
20050826 42223A100 HESG 128144 HEALTH SCIENCES GROUP INC 1
20050829 42223A100 HESG 121265 HEALTH SCIENCES GROUP INC 1
20050830 42223A100 HESG 55555 HEALTH SCIENCES GROUP INC 1
20050831 42223A100 HESG 63285 HEALTH SCIENCES GROUP INC 1
20050901 42223A100 HESG 63700 HEALTH SCIENCES GROUP INC 1
20050902 42223A100 HESG 62009 HEALTH SCIENCES GROUP INC 1
20050906 42223A100 HESG 83128 HEALTH SCIENCES GROUP INC 1
20050907 42223A100 HESG 88486 HEALTH SCIENCES GROUP INC 1
20050908 42223A100 HESG 124590 HEALTH SCIENCES GROUP INC 1
20050909 42223A100 HESG 66316 HEALTH SCIENCES GROUP INC 1
20050912 42223A100 HESG 63576 HEALTH SCIENCES GROUP INC 1
20050913 42223A100 HESG 53232 HEALTH SCIENCES GROUP INC 1
20050914 42223A100 HESG 49403 HEALTH SCIENCES GROUP INC 1
20050915 42223A100 HESG 54393 HEALTH SCIENCES GROUP INC 1
20050916 42223A100 HESG 56023 HEALTH SCIENCES GROUP INC 1
20050919 42223A100 HESG 43440 HEALTH SCIENCES GROUP INC 1
20050920 42223A100 HESG 54365 HEALTH SCIENCES GROUP INC 1
20050921 42223A100 HESG 58649 HEALTH SCIENCES GROUP INC 1
20050922 42223A100 HESG 38049 HEALTH SCIENCES GROUP INC 1
20050923 42223A100 HESG 47174 HEALTH SCIENCES GROUP INC 1
20050926 42223A100 HESG 57324 HEALTH SCIENCES GROUP INC 1
20050927 42223A100 HESG 79457 HEALTH SCIENCES GROUP INC 1
20050928 42223A100 HESG 75163 HEALTH SCIENCES GROUP INC 1
20050929 42223A100 HESG 71554 HEALTH SCIENCES GROUP INC 1
20050930 42223A100 HESG 78625 HEALTH SCIENCES GROUP INC 1
20051003 42223A100 HESG 77759 HEALTH SCIENCES GROUP INC 1
20051004 42223A100 HESG 78195 HEALTH SCIENCES GROUP INC 1
20051005 42223A100 HESG 87492 HEALTH SCIENCES GROUP INC 1
20051006 42223A100 HESG 87492 HEALTH SCIENCES GROUP INC 1
20051007 42223A100 HESG 84267 HEALTH SCIENCES GROUP INC 1
20051011 42223A100 HESG 83368 HEALTH SCIENCES GROUP INC 1
20051012 42223A100 HESG 77369 HEALTH SCIENCES GROUP INC 1
20051013 42223A100 HESG 96586 HEALTH SCIENCES GROUP INC 1
20051014 42223A100 HESG 111136 HEALTH SCIENCES GROUP INC 1
20051017 42223A100 HESG 102686 HEALTH SCIENCES GROUP INC 1
20051018 42223A100 HESG 82337 HEALTH SCIENCES GROUP INC 1
20051019 42223A100 HESG 28325 HEALTH SCIENCES GROUP INC 1
20051020 42223A100 HESG 32125 HEALTH SCIENCES GROUP INC 1
20051021 42223A100 HESG 11300 HEALTH SCIENCES GROUP INC 1
20051025 42223A100 HESG 10920 HEALTH SCIENCES GROUP INC 1
20051108 42223A100 HESG 25370 HEALTH SCIENCES GROUP INC 1
20051109 42223A100 HESG 28708 HEALTH SCIENCES GROUP INC 1
20051110 42223A100 HESG 31400 HEALTH SCIENCES GROUP INC 1
20051129 42223A100 HESG 10360 HEALTH SCIENCES GROUP INC 1
20051212 42223A100 HESG 18645 HEALTH SCIENCES GROUP INC 1
20051213 42223A100 HESG 25195 HEALTH SCIENCES GROUP INC 1
20051214 42223A100 HESG 23229 HEALTH SCIENCES GROUP INC 1
20051215 42223A100 HESG 28453 HEALTH SCIENCES GROUP INC 1
20051216 42223A100 HESG 16354 HEALTH SCIENCES GROUP INC 1
20060112 42223A100 HESG 16491 HEALTH SCIENCES GROUP INC 1
20060113 42223A100 HESG 26551 HEALTH SCIENCES GROUP INC 1
20060117 42223A100 HESG 19851 HEALTH SCIENCES GROUP INC 1
20060126 42223A100 HESG 13298 HEALTH SCIENCES GROUP INC 1
20060127 42223A100 HESG 21403 HEALTH SCIENCES GROUP INC 1
20060130 42223A100 HESG 18901 HEALTH SCIENCES GROUP INC 1
20060201 42223A100 HESG 13344 HEALTH SCIENCES GROUP INC 1
20060202 42223A100 HESG 14692 HEALTH SCIENCES GROUP INC 1
20060206 42223A100 HESG 13333 HEALTH SCIENCES GROUP INC 1
20060208 42223A100 HESG 10142 HEALTH SCIENCES GROUP INC 1
20060213 42223A100 HESG 20407 HEALTH SCIENCES GROUP INC 1
20060214 42223A100 HESG 25862 HEALTH SCIENCES GROUP INC 1
20060215 42223A100 HESG 15891 HEALTH SCIENCES GROUP INC 1
20060216 42223A100 HESG 15000 HEALTH SCIENCES GROUP INC 1
20060217 42223A100 HESG 11775 HEALTH SCIENCES GROUP INC 1
20060221 42223A100 HESG 42134 HEALTH SCIENCES GROUP INC 1
20060222 42223A100 HESG 41440 HEALTH SCIENCES GROUP INC 1
20060223 42223A100 HESG 35742 HEALTH SCIENCES GROUP INC 1
20060224 42223A100 HESG 24979 HEALTH SCIENCES GROUP INC 1
20060227 42223A100 HESG 14725 HEALTH SCIENCES GROUP INC 1
20060303 42223A100 HESG 13315 HEALTH SCIENCES GROUP INC 1
20060307 42223A100 HESG 14215 HEALTH SCIENCES GROUP INC 1
20060315 42223A100 HESG 12806 HEALTH SCIENCES GROUP INC 1
20060316 42223A100 HESG 39236 HEALTH SCIENCES GROUP INC 1
20060320 42223A100 HESG 11627 HEALTH SCIENCES GROUP INC 1
20060321 42223A100 HESG 17170 HEALTH SCIENCES GROUP INC 1
20060322 42223A100 HESG 16388 HEALTH SCIENCES GROUP INC 1
20060324 42223A100 HESG 23073 HEALTH SCIENCES GROUP INC 1
20060327 42223A100 HESG 18619 HEALTH SCIENCES GROUP INC 1
20060328 42223A100 HESG 46252 HEALTH SCIENCES GROUP INC 1
20060329 42223A100 HESG 69575 HEALTH SCIENCES GROUP INC 1
20060330 42223A100 HESG 253967 HEALTH SCIENCES GROUP INC 1
20060331 42223A100 HESG 313522 HEALTH SCIENCES GROUP INC 1
20060403 42223A100 HESG 316816 HEALTH SCIENCES GROUP INC 1
20060404 42223A100 HESG 353591 HEALTH SCIENCES GROUP INC 1
20060405 42223A100 HESG 278991 HEALTH SCIENCES GROUP INC 1
20060406 42223A100 HESG 220491 HEALTH SCIENCES GROUP INC 1
20060407 42223A100 HESG 264831 HEALTH SCIENCES GROUP INC 1
20060410 42223A100 HESG 243910 HEALTH SCIENCES GROUP INC 1
20060411 42223A100 HESG 308092 HEALTH SCIENCES GROUP INC 1
20060412 42223A100 HESG 259957 HEALTH SCIENCES GROUP INC 1
20060413 42223A100 HESG 216749 HEALTH SCIENCES GROUP INC 1
20060417 42223A100 HESG 237136 HEALTH SCIENCES GROUP INC 1
20060418 42223A100 HESG 220196 HEALTH SCIENCES GROUP INC 1
20060419 42223A100 HESG 189708 HEALTH SCIENCES GROUP INC 1
20060420 42223A100 HESG 131099 HEALTH SCIENCES GROUP INC 1
20060421 42223A100 HESG 157403 HEALTH SCIENCES GROUP INC 1
20060424 42223A100 HESG 189137 HEALTH SCIENCES GROUP INC 1
20060425 42223A100 HESG 107107 HEALTH SCIENCES GROUP INC 1
20060426 42223A100 HESG 163031 HEALTH SCIENCES GROUP INC 1
20060427 42223A100 HESG 163566 HEALTH SCIENCES GROUP INC 1
20060428 42223A100 HESG 11692 HEALTH SCIENCES GROUP INC 1
20060501 42223A100 HESG 23359 HEALTH SCIENCES GROUP INC 1
20060502 42223A100 HESG 25959 HEALTH SCIENCES GROUP INC 1
20060503 42223A100 HESG 53300 HEALTH SCIENCES GROUP INC 1
20060504 42223A100 HESG 58920 HEALTH SCIENCES GROUP INC 1
20060505 42223A100 HESG 36141 HEALTH SCIENCES GROUP INC 1
20060508 42223A100 HESG 26111 HEALTH SCIENCES GROUP INC 1
20060509 42223A100 HESG 42662 HEALTH SCIENCES GROUP INC 1
20060510 42223A100 HESG 33695 HEALTH SCIENCES GROUP INC 1
20060511 42223A100 HESG 26211 HEALTH SCIENCES GROUP INC 1
20060515 42223A100 HESG 14787 HEALTH SCIENCES GROUP INC 1
20060516 42223A100 HESG 20996 HEALTH SCIENCES GROUP INC 1
20060517 42223A100 HESG 20496 HEALTH SCIENCES GROUP INC 1
20060518 42223A100 HESG 12857 HEALTH SCIENCES GROUP INC 1
20060519 42223A100 HESG 11853 HEALTH SCIENCES GROUP INC 1
20060522 42223A100 HESG 16034 HEALTH SCIENCES GROUP INC 1
20060523 42223A100 HESG 16034 HEALTH SCIENCES GROUP INC 1
20060524 42223A100 HESG 33284 HEALTH SCIENCES GROUP INC 1
20060525 42223A100 HESG 19969 HEALTH SCIENCES GROUP INC 1
20060530 42223A100 HESG 10125 HEALTH SCIENCES GROUP INC 1
20060605 42223A100 HESG 21628 HEALTH SCIENCES GROUP INC 1
20060606 42223A100 HESG 31953 HEALTH SCIENCES GROUP INC 1
20060607 42223A100 HESG 32436 HEALTH SCIENCES GROUP INC 1
20060608 42223A100 HESG 26436 HEALTH SCIENCES GROUP INC 1
20060609 42223A100 HESG 25436 HEALTH SCIENCES GROUP INC 1
20060612 42223A100 HESG 23060 HEALTH SCIENCES GROUP INC 1
20060613 42223A100 HESG 22560 HEALTH SCIENCES GROUP INC 1
20060614 42223A100 HESG 22560 HEALTH SCIENCES GROUP INC 1
20060615 42223A100 HESG 18560 HEALTH SCIENCES GROUP INC 1
20060616 42223A100 HESG 27335 HEALTH SCIENCES GROUP INC 1
20060619 42223A100 HESG 30562 HEALTH SCIENCES GROUP INC 1
20060621 42223A100 HESG 14058 HEALTH SCIENCES GROUP INC 1
20060626 42223A100 HESG 13062 HEALTH SCIENCES GROUP INC 1
20060627 42223A100 HESG 28662 HEALTH SCIENCES GROUP INC 1
20060628 42223A100 HESG 17262 HEALTH SCIENCES GROUP INC 1
20060629 42223A100 HESG 13897 HEALTH SCIENCES GROUP INC 1
20060630 42223A100 HESG 15105 HEALTH SCIENCES GROUP INC 1
20060703 42223A100 HESG 14765 HEALTH SCIENCES GROUP INC 1
20060705 42223A100 HESG 12025 HEALTH SCIENCES GROUP INC 1
20060706 42223A100 HESG 12025 HEALTH SCIENCES GROUP INC 1
20060707 42223A100 HESG 11025 HEALTH SCIENCES GROUP INC 1
20060710 42223A100 HESG 31122 HEALTH SCIENCES GROUP INC 1
20060711 42223A100 HESG 37714 HEALTH SCIENCES GROUP INC 1
20060712 42223A100 HESG 45214 HEALTH SCIENCES GROUP INC 1
20060713 42223A100 HESG 43512 HEALTH SCIENCES GROUP INC 1
20060714 42223A100 HESG 17412 HEALTH SCIENCES GROUP INC 1
20060717 42223A100 HESG 66693 HEALTH SCIENCES GROUP INC 1
20060718 42223A100 HESG 87587 HEALTH SCIENCES GROUP INC 1
20060719 42223A100 HESG 73101 HEALTH SCIENCES GROUP INC 1
20060720 42223A100 HESG 55001 HEALTH SCIENCES GROUP INC 1
20060721 42223A100 HESG 58126 HEALTH SCIENCES GROUP INC 1
20060724 42223A100 HESG 60103 HEALTH SCIENCES GROUP INC 1
20060725 42223A100 HESG 51285 HEALTH SCIENCES GROUP INC 1
20060726 42223A100 HESG 46285 HEALTH SCIENCES GROUP INC 1
20060727 42223A100 HESG 30100 HEALTH SCIENCES GROUP INC 1
20060728 42223A100 HESG 27319 HEALTH SCIENCES GROUP INC 1
20060731 42223A100 HESG 29074 HEALTH SCIENCES GROUP INC 1
20060801 42223A100 HESG 26774 HEALTH SCIENCES GROUP INC 1
20060802 42223A100 HESG 25889 HEALTH SCIENCES GROUP INC 1
20060803 42223A100 HESG 33989 HEALTH SCIENCES GROUP INC 1
20060804 42223A100 HESG 52320 HEALTH SCIENCES GROUP INC 1
20060807 42223A100 HESG 64320 HEALTH SCIENCES GROUP INC 1
20060808 42223A100 HESG 78985 HEALTH SCIENCES GROUP INC 1
20060809 42223A100 HESG 69785 HEALTH SCIENCES GROUP INC 1
20060810 42223A100 HESG 37839 HEALTH SCIENCES GROUP INC 1
20060811 42223A100 HESG 128945 HEALTH SCIENCES GROUP INC 1
20060814 42223A100 HESG 127160 HEALTH SCIENCES GROUP INC 1
20060815 42223A100 HESG 111451 HEALTH SCIENCES GROUP INC 1
20060816 42223A100 HESG 94951 HEALTH SCIENCES GROUP INC 1
20060817 42223A100 HESG 52727 HEALTH SCIENCES GROUP INC 1
20060818 42223A100 HESG 37727 HEALTH SCIENCES GROUP INC 1
20060821 42223A100 HESG 67527 HEALTH SCIENCES GROUP INC 1
20060822 42223A100 HESG 67327 HEALTH SCIENCES GROUP INC 1
20060823 42223A100 HESG 110622 HEALTH SCIENCES GROUP INC 1
20060824 42223A100 HESG 92820 HEALTH SCIENCES GROUP INC 1
20060825 42223A100 HESG 90362 HEALTH SCIENCES GROUP INC 1
20060828 42223A100 HESG 87712 HEALTH SCIENCES GROUP INC 1
20060829 42223A100 HESG 87712 HEALTH SCIENCES GROUP INC 1
20060830 42223A100 HESG 77891 HEALTH SCIENCES GROUP INC 1
20060831 42223A100 HESG 77891 HEALTH SCIENCES GROUP INC 1
20060901 42223A100 HESG 98122 HEALTH SCIENCES GROUP INC 1
20060905 42223A100 HESG 95293 HEALTH SCIENCES GROUP INC 1
20060906 42223A100 HESG 106519 HEALTH SCIENCES GROUP INC 1
20060907 42223A100 HESG 124657 HEALTH SCIENCES GROUP INC 1
20060908 42223A100 HESG 69362 HEALTH SCIENCES GROUP INC 1
20060911 42223A100 HESG 79953 HEALTH SCIENCES GROUP INC 1
20060912 42223A100 HESG 78230 HEALTH SCIENCES GROUP INC 1
20060913 42223A100 HESG 108871 HEALTH SCIENCES GROUP INC 1
20060914 42223A100 HESG 35092 HEALTH SCIENCES GROUP INC 1
20060915 42223A100 HESG 50905 HEALTH SCIENCES GROUP INC 1
20060918 42223A100 HESG 48384 HEALTH SCIENCES GROUP INC 1
20060919 42223A100 HESG 69167 HEALTH SCIENCES GROUP INC 1
20060920 42223A100 HESG 62234 HEALTH SCIENCES GROUP INC 1
20060921 42223A100 HESG 73434 HEALTH SCIENCES GROUP INC 1
20060922 42223A100 HESG 51434 HEALTH SCIENCES GROUP INC 1
20060925 42223A100 HESG 51584 HEALTH SCIENCES GROUP INC 1
20060926 42223A100 HESG 49399 HEALTH SCIENCES GROUP INC 1
20060927 42223A100 HESG 36499 HEALTH SCIENCES GROUP INC 1
20060928 42223A100 HESG 26499 HEALTH SCIENCES GROUP INC 1
20060929 42223A100 HESG 31899 HEALTH SCIENCES GROUP INC 1
20061002 42223A100 HESG 40085 HEALTH SCIENCES GROUP INC 1
20061003 42223A100 HESG 25036 HEALTH SCIENCES GROUP INC 1
20061004 42223A100 HESG 65429 HEALTH SCIENCES GROUP INC 1
20061005 42223A100 HESG 63399 HEALTH SCIENCES GROUP INC 1
20061006 42223A100 HESG 76942 HEALTH SCIENCES GROUP INC 1
20061010 42223A100 HESG 81724 HEALTH SCIENCES GROUP INC 1
20061011 42223A100 HESG 86424 HEALTH SCIENCES GROUP INC 1
20061012 42223A100 HESG 42300 HEALTH SCIENCES GROUP INC 1
20061013 42223A100 HESG 38250 HEALTH SCIENCES GROUP INC 1
20061016 42223A100 HESG 38250 HEALTH SCIENCES GROUP INC 1
20061017 42223A100 HESG 41615 HEALTH SCIENCES GROUP INC 1
20061018 42223A100 HESG 53908 HEALTH SCIENCES GROUP INC 1
20061019 42223A100 HESG 32993 HEALTH SCIENCES GROUP INC 1
20061020 42223A100 HESG 60293 HEALTH SCIENCES GROUP INC 1
20061023 42223A100 HESG 38049 HEALTH SCIENCES GROUP INC 1
20061024 42223A100 HESG 27850 HEALTH SCIENCES GROUP INC 1
20061025 42223A100 HESG 18850 HEALTH SCIENCES GROUP INC 1
20061109 42223A100 HESG 38892 HEALTH SCIENCES GROUP INC 1
20061110 42223A100 HESG 71663 HEALTH SCIENCES GROUP INC 1
20061113 42223A100 HESG 66663 HEALTH SCIENCES GROUP INC 1
20061114 42223A100 HESG 74647 HEALTH SCIENCES GROUP INC 1
20061115 42223A100 HESG 81047 HEALTH SCIENCES GROUP INC 1
20061116 42223A100 HESG 78229 HEALTH SCIENCES GROUP INC 1
20061117 42223A100 HESG 75463 HEALTH SCIENCES GROUP INC 1
20061120 42223A100 HESG 134660 HEALTH SCIENCES GROUP INC 1
20061128 42223A100 HESG 97360 HEALTH SCIENCES GROUP INC 1
20061129 42223A100 HESG 97360 HEALTH SCIENCES GROUP INC 1
20061130 42223A100 HESG 111165 HEALTH SCIENCES GROUP INC 1
20061201 42223A100 HESG 199927 HEALTH SCIENCES GROUP INC 1
20061204 42223A100 HESG 86054 HEALTH SCIENCES GROUP INC 1
20061205 42223A100 HESG 63071 HEALTH SCIENCES GROUP INC 1
20061206 42223A100 HESG 45796 HEALTH SCIENCES GROUP INC 1
20061207 42223A100 HESG 45896 HEALTH SCIENCES GROUP INC 1
20061208 42223A100 HESG 41796 HEALTH SCIENCES GROUP INC 1
20061211 42223A100 HESG 53796 HEALTH SCIENCES GROUP INC 1
20061212 42223A100 HESG 84951 HEALTH SCIENCES GROUP INC 1
20061213 42223A100 HESG 89511 HEALTH SCIENCES GROUP INC 1
20061214 42223A100 HESG 88451 HEALTH SCIENCES GROUP INC 1
20061215 42223A100 HESG 77951 HEALTH SCIENCES GROUP INC 1
20061218 42223A100 HESG 847051 HEALTH SCIENCES GROUP INC 1
20061219 42223A100 HESG 148244 HEALTH SCIENCES GROUP INC 1
20061220 42223A100 HESG 174527 HEALTH SCIENCES GROUP INC 1
20061221 42223A100 HESG 148877 HEALTH SCIENCES GROUP INC 1
20061222 42223A100 HESG 150277 HEALTH SCIENCES GROUP INC 1
20061227 42223A100 HESG 53541 HEALTH SCIENCES GROUP INC 1
20070124 42223A100 HESG 67675 HEALTH SCIENCES GROUP INC 1
20070125 42223A100 HESG 70275 HEALTH SCIENCES GROUP INC 1
20070126 42223A100 HESG 84203 HEALTH SCIENCES GROUP INC 1
20070129 42223A100 HESG 99843 HEALTH SCIENCES GROUP INC 1
20070130 42223A100 HESG 76343 HEALTH SCIENCES GROUP INC 1
20070131 42223A100 HESG 72243 HEALTH SCIENCES GROUP INC 1
20070201 42223A100 HESG 58902 HEALTH SCIENCES GROUP INC 1
20070202 42223A100 HESG 57573 HEALTH SCIENCES GROUP INC 1
20070205 42223A100 HESG 78902 HEALTH SCIENCES GROUP INC 1
20070206 42223A100 HESG 76905 HEALTH SCIENCES GROUP INC 1
20070207 42223A100 HESG 95182 HEALTH SCIENCES GROUP INC 1
20070208 42223A100 HESG 81520 HEALTH SCIENCES GROUP INC 1
20070209 42223A100 HESG 81520 HEALTH SCIENCES GROUP INC 1
20070212 42223A100 HESG 54466 HEALTH SCIENCES GROUP INC 1
20070213 42223A100 HESG 61713 HEALTH SCIENCES GROUP INC 1
20070214 42223A100 HESG 51417 HEALTH SCIENCES GROUP INC 1
20070215 42223A100 HESG 26213 HEALTH SCIENCES GROUP INC 1
20070216 42223A100 HESG 42613 HEALTH SCIENCES GROUP INC 1
20070220 42223A100 HESG 30880 HEALTH SCIENCES GROUP INC 1
20070222 42223A100 HESG 62813 HEALTH SCIENCES GROUP INC 1
20070223 42223A100 HESG 31380 HEALTH SCIENCES GROUP INC 1
20070226 42223A100 HESG 21300 HEALTH SCIENCES GROUP INC 1
20070301 42223A100 HESG 108000 HEALTH SCIENCES GROUP INC 1
20070302 42223A100 HESG 75733 HEALTH SCIENCES GROUP INC 1
20070305 42223A100 HESG 15000 HEALTH SCIENCES GROUP INC 1
20070306 42223A100 HESG 59000 HEALTH SCIENCES GROUP INC 1
20070307 42223A100 HESG 29000 HEALTH SCIENCES GROUP INC 1
20070312 42223A100 HESG 72894 HEALTH SCIENCES GROUP INC 1
20070314 42223A100 HESG 19394 HEALTH SCIENCES GROUP INC 1
20070315 42223A100 HESG 11783 HEALTH SCIENCES GROUP INC 1
20070316 42223A100 HESG 84833 HEALTH SCIENCES GROUP INC 1
20070319 42223A100 HESG 68983 HEALTH SCIENCES GROUP INC 1
20070322 42223A100 HESG 27350 HEALTH SCIENCES GROUP INC 1
20070323 42223A100 HESG 34038 HEALTH SCIENCES GROUP INC 1
20070326 42223A100 HESG 33734 HEALTH SCIENCES GROUP INC 1
20070327 42223A100 HESG 24196 HEALTH SCIENCES GROUP INC 1
20070328 42223A100 HESG 12140 HEALTH SCIENCES GROUP INC 1
20070329 42223A100 HESG 12140 HEALTH SCIENCES GROUP INC 1
20070330 42223A100 HESG 28829 HEALTH SCIENCES GROUP INC 1
20070402 42223A100 HESG 62548 HEALTH SCIENCES GROUP INC 1
20070404 42223A100 HESG 19800 HEALTH SCIENCES GROUP INC 1
20070405 42223A100 HESG 24680 HEALTH SCIENCES GROUP INC 1
20070409 42223A100 HESG 39278 HEALTH SCIENCES GROUP INC 0.02
20070410 42223A100 HESG 25278 HEALTH SCIENCES GROUP INC 0.02
20070411 42223A100 HESG 14940 HEALTH SCIENCES GROUP INC 1
20070412 42223A100 HESG 28800 HEALTH SCIENCES GROUP INC 1
20070413 42223A100 HESG 32663 HEALTH SCIENCES GROUP INC 1
20070416 42223A100 HESG 14940 HEALTH SCIENCES GROUP INC 1
20070417 42223A100 HESG 14940 HEALTH SCIENCES GROUP INC 1
20070418 42223A100 HESG 14940 HEALTH SCIENCES GROUP INC 1
20070419 42223A100 HESG 14940 HEALTH SCIENCES GROUP INC 1
20070420 42223A100 HESG 14940 HEALTH SCIENCES GROUP INC 1
20070524 42223A100 HESG 14662 HEALTH SCIENCES GROUP INC 1
20070529 42223A100 HESG 20315 HEALTH SCIENCES GROUP INC 1
20070530 42223A100 HESG 20315 HEALTH SCIENCES GROUP INC 1
20070531 42223A100 HESG 20315 HEALTH SCIENCES GROUP INC 1
20070604 42223A100 HESG 10315 HEALTH SCIENCES GROUP INC 1
20070605 42223A100 HESG 37815 HEALTH SCIENCES GROUP INC 1
20070606 42223A100 HESG 37815 HEALTH SCIENCES GROUP INC 1
20070607 42223A100 HESG 27815 HEALTH SCIENCES GROUP INC 1
20070621 42223A100 HESG 18307 HEALTH SCIENCES GROUP INC 1
20070627 42223A100 HESG 17826 HEALTH SCIENCES GROUP INC 1
20070808 42223A100 HESG 20182 HEALTH SCIENCES GROUP INC 1
20070809 42223A100 HESG 33182 HEALTH SCIENCES GROUP INC 1
20070810 42223A100 HESG 33182 HEALTH SCIENCES GROUP INC 1
20070813 42223A100 HESG 30182 HEALTH SCIENCES GROUP INC 1
20070814 42223A100 HESG 30182 HEALTH SCIENCES GROUP INC 1
20070815 42223A100 HESG 40532 HEALTH SCIENCES GROUP INC 1
20070816 42223A100 HESG 30182 HEALTH SCIENCES GROUP INC 1
20070817 42223A100 HESG 30182 HEALTH SCIENCES GROUP INC 1
20080114 42223A100 HESG 53800 HEALTH SCIENCES GROUP INC 1
20080115 42223A100 HESG 53800 HEALTH SCIENCES GROUP INC 1
20080116 42223A100 HESG 53800 HEALTH SCIENCES GROUP INC 1
20080117 42223A100 HESG 53800 HEALTH SCIENCES GROUP INC 1
20080118 42223A100 HESG 53800 HEALTH SCIENCES GROUP INC 1
20080122 42223A100 HESG 13800 HEALTH SCIENCES GROUP INC 1
20080123 42223A100 HESG 13800 HEALTH SCIENCES GROUP INC 1
20080124 42223A100 HESG 16900 HEALTH SCIENCES GROUP INC 1
20080125 42223A100 HESG 13800 HEALTH SCIENCES GROUP INC 1
20080131 42223A100 HESG 10000 HEALTH SCIENCES GROUP INC 1
20080201 42223A100 HESG 10800 HEALTH SCIENCES GROUP INC 1
20080204 42223A100 HESG 30000 HEALTH SCIENCES GROUP INC 1
20080205 42223A100 HESG 30000 HEALTH SCIENCES GROUP INC 1
20080206 42223A100 HESG 30000 HEALTH SCIENCES GROUP INC 1
20080207 42223A100 HESG 30000 HEALTH SCIENCES GROUP INC 1
20080208 42223A100 HESG 30000 HEALTH SCIENCES GROUP INC 1
20080211 42223A100 HESG 31000 HEALTH SCIENCES GROUP INC 1
20080221 42223A100 HESG 969685 HEALTH SCIENCES GROUP INC 1
20080222 42223A100 HESG 969685 HEALTH SCIENCES GROUP INC 1
20080225 42223A100 HESG 969679 HEALTH SCIENCES GROUP INC 1
20080226 42223A100 HESG 967691 HEALTH SCIENCES GROUP INC 1
20080227 42223A100 HESG 967191 HEALTH SCIENCES GROUP INC 1
20080228 42223A100 HESG 966691 HEALTH SCIENCES GROUP INC 1
20080229 42223A100 HESG 966191 HEALTH SCIENCES GROUP INC 1
20080303 42223A100 HESG 990691 HEALTH SCIENCES GROUP INC 1
20080304 42223A100 HESG 990191 HEALTH SCIENCES GROUP INC 1
20080305 42223A100 HESG 989691 HEALTH SCIENCES GROUP INC 1
20080306 42223A100 HESG 989191 HEALTH SCIENCES GROUP INC 1
20080307 42223A100 HESG 963691 HEALTH SCIENCES GROUP INC 1
20080310 42223A100 HESG 963191 HEALTH SCIENCES GROUP INC 1
20080311 42223A100 HESG 962691 HEALTH SCIENCES GROUP INC 1
20080312 42223A100 HESG 962691 HEALTH SCIENCES GROUP INC 1
20080313 42223A100 HESG 962691 HEALTH SCIENCES GROUP INC 1
20080314 42223A100 HESG 962691 HEALTH SCIENCES GROUP INC 1
20080317 42223A100 HESG 962691 HEALTH SCIENCES GROUP INC 1
20080318 42223A100 HESG 962691 HEALTH SCIENCES GROUP INC 1
20080319 42223A100 HESG 962491 HEALTH SCIENCES GROUP INC 1
20080320 42223A100 HESG 962491 HEALTH SCIENCES GROUP INC 1
20080324 42223A100 HESG 962491 HEALTH SCIENCES GROUP INC 1
20080325 42223A100 HESG 962491 HEALTH SCIENCES GROUP INC 1
20080326 42223A100 HESG 962491 HEALTH SCIENCES GROUP INC 1
20080327 42223A100 HESG 962491 HEALTH SCIENCES GROUP INC 1
20080328 42223A100 HESG 962491 HEALTH SCIENCES GROUP INC 1
20080331 42223A100 HESG 962491 HEALTH SCIENCES GROUP INC 1
20080401 42223A100 HESG 958065 HEALTH SCIENCES GROUP INC 1
20080402 42223A100 HESG 953265 HEALTH SCIENCES GROUP INC 1
20080403 42223A100 HESG 948465 HEALTH SCIENCES GROUP INC 1
20080404 42223A100 HESG 948465 HEALTH SCIENCES GROUP INC 1
20080407 42223A100 HESG 943665 HEALTH SCIENCES GROUP INC 1
20080408 42223A100 HESG 938865 HEALTH SCIENCES GROUP INC 1
20080409 42223A100 HESG 934065 HEALTH SCIENCES GROUP INC 1
20080410 42223A100 HESG 1124744 HEALTH SCIENCES GROUP INC 1
20080411 42223A100 HESG 929744 HEALTH SCIENCES GROUP INC 1
20080721 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080722 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080723 42223A100 HESG 450300 HEALTH SCIENCES GROUP INC 1
20080724 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080725 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080728 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080729 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080730 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080731 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080801 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080804 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080805 42223A100 HESG 286300 HEALTH SCIENCES GROUP INC 1
20080806 42223A100 HESG 266300 HEALTH SCIENCES GROUP INC 1
20080807 42223A100 HESG 266300 HEALTH SCIENCES GROUP INC 1
20080808 42223A100 HESG 266300 HEALTH SCIENCES GROUP INC 1
20080811 42223A100 HESG 249900 HEALTH SCIENCES GROUP INC 1
20080812 42223A100 HESG 249900 HEALTH SCIENCES GROUP INC 1
20080813 42223A100 HESG 190100 HEALTH SCIENCES GROUP INC 1
20080814 42223A100 HESG 190100 HEALTH SCIENCES GROUP INC 1
20080902 42223A100 HESG 14400 HEALTH SCIENCES GROUP INC 1
20080903 42223A100 HESG 14400 HEALTH SCIENCES GROUP INC 1
20080904 42223A100 HESG 14400 HEALTH SCIENCES GROUP INC 1
20080905 42223A100 HESG 14400 HEALTH SCIENCES GROUP INC 1
20080908 42223A100 HESG 14400 HEALTH SCIENCES GROUP INC 1
20080909 42223A100 HESG 14400 HEALTH SCIENCES GROUP INC 1
20080910 42223A100 HESG 14400 HEALTH SCIENCES GROUP INC 1
20080911 42223A100 HESG 14400 HEALTH SCIENCES GROUP INC 1
20080912 42223A100 HESG 14400 HEALTH SCIENCES GROUP INC 1
20080915 42223A100 HESG 13400 HEALTH SCIENCES GROUP INC 1
20080918 42223A100 HESG 40000 HEALTH SCIENCES GROUP INC 1
20081015 42223A100 HESG 10000 HEALTH SCIENCES GROUP INC 1
20081205 42223A100 HESG 470202 HEALTH SCIENCES GROUP INC 1
20090203 42223A100 HESG 20650 HEALTH SCIENCES GROUP INC 1
20090212 42223A100 HESG 4079995 HEALTH SCIENCES GROUP INC 1
20090213 42223A100 HESG 9714833 HEALTH SCIENCES GROUP INC 1
20090217 42223A100 HESG 18939389 HEALTH SCIENCES GROUP INC 1
20090220 42223A100 HESG 32269999 HEALTH SCIENCES GROUP INC 1
20090224 42223A100 HESG 8456103 HEALTH SCIENCES GROUP INC 1
20090225 42223A100 HESG 400000 HEALTH SCIENCES GROUP INC 1
20090317 42223A100 HESG 23347 HEALTH SCIENCES GROUP INC 1
20090318 42223A100 HESG 23347 HEALTH SCIENCES GROUP INC 1
20090401 42223A100 HESG 100000 HEALTH SCIENCES GROUP INC 1
20090415 42223A100 HESG 62384 HEALTH SCIENCES GROUP INC 1
20090416 42223A100 HESG 62384 HEALTH SCIENCES GROUP INC 1
20090417 42223A100 HESG 62384 HEALTH SCIENCES GROUP INC 1
20090427 42223A100 HESG 250000 HEALTH SCIENCES GROUP INC 1
20090504 42223A100 HESG 910461 HEALTH SCIENCES GROUP INC 1
20090601 42223A100 HESG 158000 HEALTH SCIENCES GROUP INC 1
20090701 42223A100 HESG 5000 HEALTH SCIENCES GROUP INC 1
20090702 42223A100 HESG 5000 HEALTH SCIENCES GROUP INC 1
20090706 42223A100 HESG 602493 HEALTH SCIENCES GROUP INC 1
20090707 42223A100 HESG 602493 HEALTH SCIENCES GROUP INC 1
20090708 42223A100 HESG 213152 HEALTH SCIENCES GROUP INC 1
Wow HESG has never, ever, ever had a problem updating FTDs..
Your right we should file with SEC, I'll do it myself if FTD's fail to update.... but having all of you file would also help.
SEC Question:
Why has Failure To Deliver data for HESG/ Health Sciences Group Inc.... have not been updated since July 8th, 2009? The Company has seen lifetime record volume since that date, would it be possible to receive an answer regarding the HESG delay for SEC transparency?
Is it true this data will be updated as soon as the SEC provides a new update? The last update included 1st half of June 2010 data and was added on 6/30/2010. As of July 2009, the SEC will begin releasing updated data on a two week delay instead of quarterly...is that still true?.
42223A100 HESG
Thank You For Your Service,
Everyday HESG Investor.
(bagholder name here)
enforcement-related information, please send it in an email to enforcement@sec.gov
Investors can also file complaints at www.sec.gov/complaint.shtml
So HESG Future-Now... rest in your hands.... what will the "bagholders" do?
12. I read on an internet chat room or website that a specific security has a large number of fails; are these sources reliable?
Quote:
Investors should always be cautious that issuers, promoters, or shareholders may be seeking to stimulate buying interest by making false, misleading or unfounded statements in internet chat rooms or other such forums about alleged large naked short positions in some smaller issuers, particularly those trading on the OTCBB or Pink Sheets. Some individuals may encourage other investors to buy these issuers' securities by claiming that there will be an imminent "short squeeze," in which the alleged naked short sellers will be forced to cover open short positions at increasing prices. These claims in fact may be false.
The Commission's Office of Investor Education and Assistance has made available publications on the Commission's Internet web site (www.sec.gov) that provide helpful guidance on the securities markets and sales and trading practices, including short selling. Investors and prospective investors should be cautious of rumors on chat rooms where the intent of nameless and faceless computer users is in doubt.
13. Where can I find information on specific issuers or securities?
To find information on issuers and securities, see www.sec.gov/investor/pubs/easyaccess.htm.
14. Does NSCC's stock borrow program create "counterfeit shares?"
NSCC's stock borrow program, as approved by the Commission, permits NSCC to borrow securities from its participants for the purpose of completing settlements only if participants have made those securities available to NSCC for this purpose and those securities are on deposit in the participant's account at DTC.
15. Where can I submit information on potential violations of the federal securities laws?
If you have specific enforcement-related information, please see www.sec.gov/complaint.shtml for information on how to submit a complaint. You may also call 1-800-SEC-0330.
16. Where can I find information on investigations or enforcement actions pending against specific issuers or regarding specific securities?
As a policy, the SEC will neither confirm nor deny the existence of an investigation unless, and until, it becomes a matter of public record as the result of a court action or administrative proceeding. SEC investigations are conducted on a non-public and confidential basis to help assure the integrity of the investigative process. See http://www.sec.gov/investor/pubs/howoiea.htm for more information on how the Commission handles complaints.
To view enforcement actions that the Commission has taken, see http://www.sec.gov/litigation/litreleases.shtml.
VI. Reporting Alleged Abusive Naked Short Selling Activity
The markets and the SROs are primarily responsible for the surveillance and enforcement of trading activity pursuant to their rules. The SEC, however, independently or in conjunction with the SROs and other regulatory authorities, actively investigates and prosecutes violations of the federal securities laws.
The SEC takes information alleging violations of the federal securities laws very seriously. If you have specific enforcement-related information, please send it in an email to enforcement@sec.gov. Please note, however, the SEC will neither confirm nor deny the existence of an investigation unless, and until, it becomes a matter of public record as the result of a court action or administrative proceeding. As you may also be aware, SEC investigations are conducted on a non-public and confidential basis to help assure the integrity of the investigative process. See http://www.sec.gov/investor/pubs/howoiea.htm for more information on how the Commission handles complaints.
VII. Regulation SHO – Releases and Other Guidance
The final adopting release for Regulation SHO and other key documents relating to short sale regulation, such as the "Frequently Asked Questions Regarding Regulation SHO" published by the Staff of the Division of Market Regulation, are available on the Commission's website at: http://www.sec.gov/spotlight/shortsales.htm.
The NasdaqTrader has also issued guidance on Regulation SHO through a Frequently Asked Questions release on its website at: http://www.nasdaqtrader.com/trader/hottopics/RegSHOFAQs.pdf.
VIII. Who Do I Contact If I Have Questions about Regulation SHO?
Individual investors who have comments or information should feel free to contact the SEC's Office of Investor Education and Assistance at 1-800-SEC-0330 or (202) 942-7040. Investors can also file complaints at http://www.sec.gov/complaint.shtml.
http://www.sec.gov/spotlight/keyregshoissues.htm
Quote:
Which Companies File Reports With the SEC?
In general, the federal securities laws require all but the smallest public companies to file reports with the SEC - including companies with 500 or more investors and $10 million or more in assets, companies that list their securities on a major national exchange (such as the New York Stock Exchange or the Nasdaq Stock Market), and companies whose securities are quoted on the OTC Bulletin Board.
These reports that a company files with the SEC - including annual reports (with audited financial statements) on Form 10-K, quarterly reports on Form 10-Q, and periodic reports of significant events on Form 8-K - contain a treasure trove of important information about the company's management, business, and financial condition and can tell you whether the company is making money or losing money and why. Any investor can access (for free) these and other documents by searching the SEC's EDGAR database of company filings.
What Information Do I Need?
Especially if you are investing on your own, be sure to research each investment opportunity thoroughly and ask questions - about both the company itself and the person or entity promoting it. These simple steps can help you make an informed investment decision:
1. Research the Company: If you can't find the company on EDGAR, be sure to contact your state securities regulator. Read carefully the most recent reports the company has filed with its regulators. Make sure you understand the company's business and its products or services. And pay attention to the company's financial statements - particularly if they are not audited or not certified by an accountant. If the company does not file reports with the SEC, be sure to ask your broker for what's called the "Rule 15c2-11 file" on the company. That file will contain important information about the company.
2. Know the Owners: Contact your state securities regulator to check out the people running the company. Be sure to find out whether they have a history of investor complaints or fraud charges. It pays to know whether the company's management has made money for investors in the past - or not.
3. Check Out Your Broker: Make sure the broker and his or her firm are registered and licensed to do business in your state. And ask your state securities regulator whether the broker and the firm have ever been disciplined or have complaints against them.
We've spelled out many additional questions you'll need to ask in our publications entitled Internet Fraud and Ask Questions. When you ask these questions, write down the answers you received and what you decided to do. If something goes wrong, your notes can help to establish who said what and when. Let your broker or investment adviser know you're taking notes. They'll know you're a serious investor and may tell you more - or give up trying to scam you.
How Do I Get Information About Companies?
If you're working with a broker or an investment adviser, he or she can provide you with information about the company and its disclosure documents. Be sure to read carefully the prospectus and the company's latest financial reports. Remember that unsolicited emails, message board postings, and company news releases should never be used as the sole basis for your investment decisions. You can also get information on your own from these sources:
* From the company Ask the company if it is registered with the SEC and files reports with us. If the company is small and unknown to most people, you should also call your state securities regulator to get information about the company, its management, and the brokers or promoters who've encouraged you to invest in the company.
* From the SEC A great many companies must file their reports with the SEC. Using the EDGAR database, you can find out whether a company files with us and get any reports in which you're interested. For companies that do not file on EDGAR, check with the SEC's Public Reference Room to see whether the company has filed an offering circular under Regulation A.
* From your state securities regulator We strongly urge you to contact your state securities regulator to find out whether they have information about a company and the people behind it. Look in the government section of your phone book or visit the website of the North American Securities Administrators Association to get the name and phone number. Even though the company does not have to register its securities with the SEC, it may have to register them with your state. Your regulator will tell you whether the company has been legally cleared to sell securities in your state. Too many investors could easily have avoided heavy and painful financial losses if they only called their state securities regulator before they bought stock.
* From other government regulators Many companies, such as banks, do not have to file reports with the SEC. But banks must file updated financial information with their banking regulators. Visit the Federal Reserve System's National Information Center of Banking Information site at www.ffiec.gov/nicpubweb/nicweb/nichome.aspx, the Office of the Comptroller of the Currency at www.occ.treas.gov, or the Federal Deposit Insurance Corporation at www.fdic.gov.
* From reference books and commercial databases Visit your local public library or the nearest law or business school library. You'll find many reference materials containing information about companies. You can also access commercial databases for more information about the company's history, management, products or services, revenues, and credit ratings. The SEC cannot recommend or endorse any particular research firm, its personnel, or its products. But there are a number of commercial resources you may consult, including: Bloomberg, Dun & Bradstreet, Hoover's Profiles, Lexis-Nexis, and Standard & Poor's Corporate Profiles. Ask your librarian about additional resources.
* From the Secretary of State where the company is incorporated Contact the secretary of state where the company is incorporated to find out whether the company is a corporation in good standing. You may also be able to obtain copies of the company's incorporation papers and any annual reports it files with the state. Please visit the National Association of Secretaries of State website at www.nass.org for contact information regarding a particular Secretary of State.
What Are the "Red Flags"?
It can be extraordinarily difficult to detect fraud or a manipulative scheme. But when you're researching a company, watch out for these "red flags":
* SEC Trading Suspensions The SEC has the power to suspend trading in any stock for up to 10 days when it believes that information about the company is inaccurate or unreliable. Think twice before investing in a company that's been the subject of an SEC trading suspension. You'll find information about trading suspensions on the SEC's website.
* Company Recommended But No Current Information Be especially careful if you receive an unsolicited fax or e-mail about a company -- or see it praised on an Internet bulletin board -- but can find no current financial information about the company from other independent sources. Many fraudsters use e-mail, faxes and Internet postings to tout thinly traded stocks, in the hopes that the resulting buying frenzy will push the share price up so that they can sell their shares. Once they dump their stock and quit promoting the company, the share price quickly falls.
* High Pressure Sales Tactics Beware of salespeople who pressure you to buy before you have a chance to think about and investigate the "opportunity." Dishonest people may try to tell you about a "once-in-a-lifetime" opportunity or one that's based on "inside" or "confidential" information. Don't fall for a promise of spectacular profits or "guaranteed" returns. These are the hallmarks of fraud. If the deal sounds too good to be true, then it probably is.
* Assets Are Large But Revenues Are Small Companies will sometimes assign high values on their financial statements to assets that have nothing to do with their business. Find out whether there's a valid explanation for low revenues, especially when the company claims to have large assets.
* Odd Items in the Footnotes to the Financial Statements Many fraud schemes involve unusual transactions among individuals connected to the company. These can be unusual loans or the exchange of questionable assets for company stock that may be discussed in the footnotes.
* Unusual Auditing Issues Be wary when a company's auditors have refused to certify the company's financial statements or if they've stated that the company may not have enough money to continue operating. Also question any change of accountants.
* Insiders Own Large Amounts of the Stock In many fraud cases - especially "pump and dump" schemes - the company's officers and promoters own significant amounts of the stock. When one person or group controls most of the stock, they can more easily manipulate the stock's price at your expense. You can ask your broker or the company whether one person or group controls most of the company's stock, but if the company is the subject of a scam, you may not get an honest answer.
Additional Warning Signs Don't deal with anyone who refuses to provide you with written information about the investments they're promoting. Never tell a cold caller your social security number or numbers for your banking and securities accounts. And be extra wary if someone you don't know and trust recommends foreign or "off-shore" investments. For more tips on avoiding danger, be sure to read Cold Calling and The Fleecing of Foreign Investors.
What About Bankruptcy?
Watch out for ticker symbols ending with a fifth letter "Q." The addition of a "Q" to a company's stock ticker symbol indicates that the company has filed for or is involved in bankruptcy proceedings. Investors often snatch up the low-priced shares of companies that have filed for Chapter 11 protection, speculating that the price will rise once the company emerges from bankruptcy. But that's not how bankruptcy typically works.
Be cautious when buying common stock of companies in Chapter 11 bankruptcy. Doing so is extremely risky and will likely lead to financial loss. Although a company may emerge from bankruptcy as a viable entity, in most instances, the company's plan of reorganization will cancel the existing equity shares. It is generally the creditors and the bondholders who become the new owners of the company's new shares - not the stockholders. This happens in bankruptcy cases because creditors are paid from the company's assets before common stockholders. And in situations where shareholders do participate in the plan, their shares are usually subject to substantial dilution. If you have questions about what happens when a company declares bankruptcy, you can get information from our brochure on the subject.
Where Can I Turn for Help?
If you've been asked to invest in a company but you can't find any record that the company has registered its securities with the SEC or your state, or that it's exempt from registration, you may have come face to face with a scam. Call or write your state's securities regulator immediately with all the details. You can also file a complaint using the SEC's online Complaint Center.
www.sec.gov/answers/infomatters.htm
We have provided this information as a service to investors. It is neither a legal interpretation nor a statement of SEC policy. If you have questions concerning the meaning or application of a particular law or rule, please consult with an attorney who specializes in securities law.
Legal & Regulatory
SEC Rule Filings
Quote:All services provided through the clearing corporations and depository are registered with and regulated by the U.S. Securities and Exchange Commission (SEC). The depository is also a member of the U.S. Federal Reserve System and a limited purpose trust company under New York State banking law.
Related Information
* The Depository Trust Company (DTC) SEC Rule Filings
* Rules, By-Laws and Organization Certificate of The Depository Trust Company
The Depository Trust Company (DTC)
DTCC's subsidiary, The Depository Trust Company, established in 1973, was created to reduce costs and provide clearing and settlement efficiencies by immobilizing securities and making "book-entry" changes to ownership of the securities. DTC provides securities movements for NSCC's net settlements, and settlement for institutional trades (which typically involve money and securities transfers between custodian banks and broker/dealers), as well as money market instruments.
Related Information
* National Securities Clearing Corporation (NSCC) SEC Rule Filings
* Rules and Procedures of National Securities Clearing Corporation
National Securities Clearing Corporation (NSCC)
DTCC's subsidiary, National Securities Clearing Corporation (NSCC), established in 1976, provides clearing, settlement, risk management, central counterparty services and a guarantee of completion for certain transactions for virtually all broker-to-broker trades involving equities, corporate and municipal debt, American depositary receipts, exchange-traded funds, and
unit investment trusts.
http://www.dtcc.com/legal/rule_filings/
How often is this data updated?
This data will be updated as soon as the SEC provides a new update. The last update included 1st half of June 2010 data and was added on 6/30/2010. As of July 2009, the SEC will begin releasing updated data on a two week delay instead of quarterly.
Self Regulators, Why YES We Are....
HESG Shareholders Know What Is Best.....
Just-ICE for All & All for Justice
ICE*LITE Seeking CEO's, that will lets us know. http://www.litecapital.com
One could hope for a forced buy-in
Has that ever hapened I don't think the SEC has those kind of BALLS!
EZEy
The only news I want from these bums is that they are closeing up shop and stealing off into the night.
Dropping by is good but I was wondering if it would not be a good idea to pump one where knight was on the run and the people who are burying them need help.
Well said my friend. They will get theirs and it won't be long from now. They are trapped on company's that have made it and will cry the blues of the trapped shorter. I'm going to make it a point to live long enough to see you go belly up.
Hello Nite....It's great to see pennyland investor come to this board.And express how they feel.You see!Your greed affect LiL ppl like me and others.That are looking for a fair chance on there investment.You get fined millions.But you make Billions.Just to let you no...Pennyland investor are learning how to play this game.And will continue to get better and better at it with each passing day.....Nite Fleas
Keep shorting stocks NITE! Short my long sale out of my account today because you never delivered the shares you shorted me in the first place?
I will be laying on a beach the following week!
next week(s) is here
Germany ban on naked short selling and Goldman Sachs ties
SiriusNews on Jun 7, 2010 06:34 PM
To News Media worldwide, I want to write this letter to clearly put together the story about what took place on Wall Street since the elimination of the uptick rule on July 6th, 2007 up until the current crisis in the United States as of today June 2010, just weeks away from financial reform to be signed into Law here in the United States. May 2007 Goldman Sachs hired math wiz computer programmer Segei Aleynikov July 2007 Up Tick rule abolished and Naked Short Selling Scandal begins as Housing scandal ends July 2007 Massive downgrades in credit ratings as the Housing scandal slows and Goldman Sachs moves into Stock Scandal FY 2008 U.S in a full blown recession due to financial crisis and naked short selling and other scandals tied to Goldman Sachs and others June 2008 Secret meeting in Moscow between Goldman Sachs board members and Hank Paulson Sept 2008 Financial meltdown and Last days of Lehman Brothers. Hank calls Loydd 24 times within a few days July 3rd 2009 FBI arrest Segei Aleynikov as he had sent over 1,000 secret codes and files to German Web Site Feb 24th, 2010 Up tick rule voted back in but with some circuit breakers April 15th 2010 Goldman Sachs tied to Galleon trading investigation April 16th, 2010 Goldman Sachs Civil Fraud Charges brought by Government/SEC May 4th, 2010 Goldman Sachs guilty of Naked Short Selling and pays fine May 6th, 2010 Stock market crash down 700 ponts is minutes to almost down 1,000 points on day. still looking for answers in an ongoing investigation. May 18th, 2010 Germany bans naked short selling. What does the German secret service know about the Goldman Sachs secret files sent to German web site? Now today, Newsweek comes out with a story June 7th, 2010 on page 42, where they state the arrest ofthe Goldman Sachs computer programmer. Newsweek June 7th, 2010 page 42. http://bit.ly/cbM89b Goldman Sachs secret codes/ arrest These facts are all connected, yet the News media has not put the story together. see these two video's on youtube that just came out, that clearly explains the connections and it all leads back to Goldman Sachs. part 1 Utube
I will be here to cheer that $7 on....hahaha!
YES!!!!
spent most of the day $13.80-$14.00
Love the direction Its headed.$7.00 by years end?????
Have I said I hate Knight Trading Group recently? If not...
I HATE KNIGHT TRADING GROUP.
There. I feel better already : )
Followers
|
80
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9190
|
Created
|
04/05/02
|
Type
|
Free
|
Moderators |
Knight Capital Group, Inc. (collectively with its subsidiaries, "Knight" or the "Company") is a global financial services firm that provides access to the capital markets across multiple asset classes to a broad network of clients, including broker-dealers, institutions and corporations. The Company seeks to continually apply its expertise and innovation to the market making and trading process to build lasting client relationships through consistent performance and superior client service. The Company has four operating segments: (i) Market Making, (ii) Institutional Sales and Trading, (iii) Electronic Execution Services and (iv) Corporate and Other.
Market Making
The Market Making segment principally consists of market making in global equities and listed domestic options. As a market maker, the Company commits capital for trade executions by offering to buy securities from, or sell securities to, institutions and broker-dealers. The Market Making segment primarily includes client, and to a lesser extent, non-client electronic market making activities in which the Company operates as a market maker in equity securities quoted and traded on the Nasdaq Stock Market; the over-the-counter ("OTC") market for New York Stock Exchange ("NYSE"), NYSE Amex Equities ("NYSE Amex"), NYSE Arca listed securities; and several European exchanges. As a complement to electronic market making, the Company's cash trading business handles specialized orders and also transacts on the OTC Bulletin Board, the OTC Pink Markets and the Alternative Investment Market ("AIM") of the London Stock Exchange. The segment provides trade executions as an equities Designated Market Maker ("DMM") on the NYSE and NYSE Amex. The Market Making segment also includes the Company's option market making business which trades on substantially all domestic electronic exchanges.
Institutional Sales and Trading
The Institutional Sales and Trading segment includes global equity, exchange traded funds ("ETFs"), and fixed income sales; reverse mortgage origination and securitization; capital markets; and asset management activities. The primary business of the Institutional Sales and Trading segment is to execute and facilitate equities, ETFs and fixed income transactions as an agent on behalf of institutional clients, and commits capital on behalf of clients when needed. This is predominantly a full-service execution business, in which much of the interaction is based on the Company's client relationships. This segment also facilitates client orders through program and block trades and riskless principal trades and provides capital markets services, including equity and debt private placement.
Electronic Execution Services
The Electronic Execution Services segment offers access via its electronic agency-based platforms to markets and self-directed trading in equities, options, fixed income, foreign exchange and futures. In contrast to Market Making, the businesses within this segment generally do not act as a principal to transactions that are executed and generally earn commissions for acting as an agent between the principals to the trade.
Corporate and Other
The Corporate and Other segment invests in strategic financial services-oriented opportunities, allocates, deploys and monitors all capital, and maintains corporate overhead expenses and all other income and expenses that are not attributable to the other segments. The Corporate and Other segment houses functions that support the Company's other segments such as self-clearing services, including stock lending activities.
Discontinued Operations
Discontinued operations comprises costs associated with shutting down the Company's former Deephaven Capital Management business which was discontinued in 2009.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |